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Durante il Dottorato di ricerca mi sono occupata dello studio della 
regolazione dell‘espressione genica in Neisseria menigitidis. In particolare 
la mia attenzione si è focalizzata sulla regolazione mediata da piccoli RNA 
non codificanti (sRNAs). Ho studiato il fenotipo di un mutante knock-out 
del gene dell‘RNA chaperone hfq e ho identificato e caratterizzato 2 nuovi 
sRNAs in meningococco e i loro rispettivi circuiti di regolazione. Ho inoltre 
identificato altri possibili nuovi sRNAs attraverso l‘analisi del trascrittoma 
di N. menignitidis tramite la tecnologia ―Illumina sequencing‖. Infine, ho 
anche caratterizzato il circuito di regolazione di un regolatore trascrizionale 
della famiglia AraC.  
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RIASSUNTO 
 
I piccoli RNA batterici (sRNAs) sono regolatori post-trascrizionali 
coinvolti nelle risposte a diversi stress. Questi piccoli trascritti non 
codificanti sono sintetizzati in risposta a un certo segnale e controllano 
l‘espressione genica dei loro reguloni modulando la traduzione o la stabilità 
di mRNA targets, spesso insieme all‘ RNA chaperone Hfq. In questa tesi si 
è caratterizzato in Neisseira meningitidis un mutante knock out per il gene 
hfq, dimostrando che ha un fenotipo pleiotropico. Questo suggerisce un 
importante ruolo della proteina Hfq nell‘adattamento agli stress e nella 
virulenza del batterio, nonchè la presenza di sRNAs dipendenti da Hfq. 
Inoltre, un‘analisi globale dell‘espressione genica, per identificare trascritti 
regolati nel mutante di Hfq, ha rivelato l‘esistenza di uno sRNA, 
impropriamente annotato come una open reading frame (ORF), che 
abbiamo chiamato AniS. Si è dimostrato che la sintesi di questo nuovo 
sRNA è indotta in condizioni di anaerobiosi, grazie all‘azione del 
regolatore trascrizionle FNR che ne attiva la trascrizione. Abbiamo inoltre 
identificato 2 possibili targets di AniS attraverso analisi dell‘espressione 
genica globale.  
In questa tesi si è anche effettuata una dettagliata analisi molecolare 
dell‘azione dello sRNA NrrF, il primo ad essere stato identificato in N. 
meningitidis. Si dimostra che NrrF regola la succinato deidrogenasi 
formando un duplex con una zona di complementareità all‘interno della 
regione sdhDA del trascritto della succinato deidrogenasi. Hfq aumenta 
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l‘efficenza del legame tra i 2 RNA e questo probabilmente determina una 
rapida degradazione del trascritto in vivo. Inoltre,allo scopo di identificare 
altri possibili sRNAs in N. menigitidis abbiamo sequenziato il trascrittoma 
del batterio in condizioni standard di crescita in vitro e in condizioni di 
carenza di ferro. Questa analisi ha rivelato geni che sono attivamente 
trascritti nelle 2 condizioni. La nostra attenzione si è rivolta in particolare 
alle regioni non codificanti attivamente trascritte nel genoma. Questo ha 
permesso di identificare 19 possibili nuovi sRNAs e regioni 5‘ e 3‘ UTRs 
(regioni non tradotte). Ulteriori studi saranno focalizzati sull‘identificazione 
dei circuiti regolatori di questi sRNAs e sui loro targets. 
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ABSTRACT 
 
Bacterial small regulatory RNAs (sRNAs) are posttranscriptional regulators 
involved in stress responses. These short non-coding transcripts are 
synthesised in response to a signal, and control gene expression of their 
regulons by modulating the translation or stability of the target mRNAs, 
often in concert with the RNA chaperone Hfq. Characterization of a Hfq 
knock out mutant in Neisseria meningitidis revealed that it has a pleiotropic 
phenotype, suggesting a major role for Hfq in adaptation to stresses and 
virulence and the presence of Hfq-dependent sRNA activity. Furthermore, 
global gene expression analysis of regulated transcripts in the Hfq mutant 
revealed the presence of a regulated sRNA, incorrectly annotated as an 
open reading frame, which we renamed AniS. We demonstrated that the 
synthesis of this novel sRNA is anaerobically induced through activation of 
its promoter by the FNR global regulator and through global gene 
expression analyses we identified at least two predicted mRNA targets of 
AniS. 
In this thesis we also performed a detailed molecular analysis of the action 
of the sRNA NrrF, the first one identified in N. meningitidis. We 
demonstrated that NrrF regulates succinate dehydrogenase by forming a 
duplex with a region of complementarity within the sdhDA
 
region of the 
succinate dehydrogenase transcript, and Hfq enhances
 
the binding of this 
sRNA to the identified target in the sdhCDAB
 
mRNA; this is likely to result 
in rapid turnover of the transcript
 
in vivo.  
In addition, in order to globally investigate other possible sRNAs of N. 
meningitdis we Deep-sequenced the transcriptome of this bacterium under 
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both standard in vitro and iron-depleted conditions. This analysis revealed 
genes that were actively transcribed under the two conditions. We focused 
our attention on the transcribed non-coding regions of the genome and, 
along with 5‘ and 3‘ untranslated regions, 19 novel candidate sRNAs were 
identified. Further studies will be focused on the identification of the 
regulatory networks of these sRNAs, and their targets. 
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INTRODUCTION 
 
1.1  Meningococcal disease 
 
 
N. meningitidis is a strictly human pathogen responsible for meningitis and 
sepsis, two devastating diseases that can kill children and young adults 
within hours, despite the availability of effective antibiotics. 
Studies performed in Europe (Caugant et al., 2007) have demonstrated that 
carriage rates are very low in the first few years of life, but sharply rise 
during adolescence, peaking at 10–35% in 20–24-year olds, before 
decreasing to less than 10% in older age groups (Caugant et al, 2007; Claus 
et al., 2005). Compared with the carriage rate, meningococcal disease is 
rare, and disease rates vary in different geographic regions of the world 
(Hill et al., 2010). What changes the colonization state of the organism into 
a disease state is not entirely clear. It appears that a combination of bacterial 
virulence factors and host susceptibility, including age, prior viral infection, 
smoking (Cartwright & Ala'Aldeen, 1997) and genetic polymorphisms 
(reviewed in Emonts et al., 2003) may ultimately lead to meningococcal 
disease. The human nasopharyngeal mucosa, in fact, is the only natural 
reservoir of N. meningitidis, however meningococcus can invade the 
pharyngeal mucosal epithelium and, in the absence of bactericidal serum 
activity, disseminate into the bloodstream, causing septicaemia. In a subset 
of cases, the bacteria can also cross the blood-brain barrier and infect the 
cerebrospinal fluid, causing meningitis.  
In general, mortality occurs in up to 10% of patients with invasive 
meningococcal disease (Stephens, 2007). Mortality rates are dependent on 
the type and severity of invasive disease, and are greatest for fulminant 
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septicaemia (up to 55%) followed by meningitis with associated 
septicaemia (up to 25%), and lowest for meningitis without sepsis 
(generally <5%) (Brandtzaeg & van Deuren, 2005). However, patients who 
survive invasive meningococcal disease often live with a number of 
physical and mental sequelae, including amputation of limbs and digits, 
scarring of skin, speech impairment and seizures (Borg et al., 2009). 
 
1.2 The pathogen 
N. meningitidis is a Gram-negative diplococcus (Fig. 1). It is aerobic, non-
motile, non-sporulating, usually encapsulated and piliated. Traditionally 
different N. meningitidis strains are classified into serogroups according to 
the immunological reactivity of their capsule polysaccharides. With this 
method 13 different serogroups have been identified, but only A, B, C, Y, X 
and W135 commonly cause invasive infections. Meningococci are further 
classified into serotype and serosubtype, based on antigenic differences in 
their major outer membrane proteins (OMPs), PorA and PorB. The 
serological classification system, however, is limited due to high frequency 
of phase and antigenic variation of outer-membrane structures, which has 
led to the development of DNA-based approaches to characterize 
meningococcal strains. The most important of these methods is multilocus 
sequence typing (MLST), which characterizes isolates on the basis of the 
nucleotide sequences of internal fragments of seven housekeeping genes 
defining their sequence type (ST) (Maiden et al., 1998). Menigococci can in 
this way be classified into lineages, termed clonal complexes (cc). A clonal 
complex is a group of STs that share at least four of the seven loci in 
common with a central ancestral genotype. Despite huge diversity in 
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meningococcal population, only a minority of these clonal complexes are 
associated with invasive disease, known as hyperinvasive lineages (Maiden, 
2008). Why hyperinvasive meningococcal lineages are more pathogenic 
than others remain still unknown. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: ImmunoGold labelling and transmission electron microscopy of N. 
meningitidis. Analysis of the strain was performed with antisera raised against NadA 
adhesin (Scale bars: 200 nm.) (Pizza et al., 2000) 
 
1.3 Colonization and invasion  
Colonization of the upper respiratory mucosal surfaces by N. meningitidis is 
the first step in the establishment of a human carrier state and invasive 
meningococcal disease (Stephens, 2009). Initial contact with 
nasopharyngeal epithelial cells is mediated by Type IV pili. Then, 
meningococci proceed to proliferate on the surface of human non-ciliated 
epithelial cells, forming small microcolonies at the site of initial attachment 
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(Stephens, 2009). After the initial colonization, there is a loss or down 
regulation of the capsule, which sterically masks the outer membrane 
proteins. This event is thought to occur both via cell contact induced 
repression (Deghmane et al., 2002), and by selection of low or no-capsule 
expressing bacteria due to phase variation (Hammerschmidt et al., 1996). 
Close adherence of meningococci to the host epithelial cells is mediated by 
a variety of possible redundant adhesins, previously masked by the capsule. 
This results in the appearance of cortical plaques and the recruitment of 
factors leading to the formation and extension of epithelial cell pseudopodia 
that internalize the bacteria (Stephens, 2009). Once internalized in the 
epithelial cells meningococcus can evade the host immune response, find 
more available nutrients and can also cross the epithelium and enter the 
bloodstream (Stephens, 2009).  Intracellular survival is determined by 
factors including IgA1 protease, which degrades lysosome-associated 
membrane proteins, and upregulation of expression of capsule, which is 
anti-opsonic and anti-phagocitic and therefore aids survival in blood 
(Stephens, 2009; (Virji, 2009)). (Fig 2). The next steps of meningococcal 
invasion of the bloodstream and the passage across the brain vascular 
endothelium, which results in infection of the meninges and the 
cerebrospinal fluid, are still poorly understood.  
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                                                                                                                                              Virji, 2009 
Figure 2: Stages in the pathogenesis of N. meningitidis. N. meningitidis may be acquired 
through the inhalation of respiratory droplets. The organism establishes intimate contact 
with non-ciliated mucosal epithelial cells of the upper respiratory tract, where it may enter 
the cells briefly before migrating back to the apical surfaces of the cells for transmission to 
a new host. Asymptomatic carriage is common in healthy adults in which bacteria that enter 
the body by crossing the epithelial barrier are eliminated. Besides transcytosis, N. 
meningitidis can cross the epithelium either directly following damage to the monolayer 
integrity or through phagocytes in a ‗Trojan horse‘ manner. In susceptible individuals, once 
inside the blood, N. meningitidis may survive, multiply rapidly and disseminate throughout 
the body and the brain. Meningococcal passage across the brain vascular endothelium (or 
the epithelium of the choroid plexus) may then occur, resulting in infection of the meninges 
and the cerebrospinal fluid (Nassif, 1999). 
 
1.4 Virulence factors  
The major virulence factor (Fig 3) of meningococcus is the polysaccharide 
capsule that protects the bacterium during airborne transmission between 
hosts (Romero & Outschoorn, 1997), confers protection from effectors of 
the innate immunity (Vogel et al., 1997), allows survival in blood, as 
mentioned before, and may shield bacterial surface from the host immune 
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effectors mechanisms (Virji, 2009). The second principle virulence factor, 
mainly involved in the interface between the host and the bacterium, are the 
pili, long surface proteins that protrude from the capsule.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Virulence factors in meningococcal cell membranes (from Rosenstein et al., 2001) 
 
Together with the outer membrane adhesins, pili facilitate adhesion to host 
tissues having a crucial role in the initial establishment of encapsulated 
bacteria on mucosal surfaces, helping the penetration of the negatively 
charged barrier at the host-pathogen interface (Heckels et al., 1976). In 
addition to adhesion, pili, are involved in several other functions, for 
example facilitating uptake of foreign DNA from the extracellular 
environment, increasing transformation frequency of bacteria and 
maintaining the genetic diversity that supports the success of Neisseria in 
the human host (Helaine et al., 2007). The pilus of meningococcus is 
expressed from the pilE locus, but homologous recombination between the 
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pilE gene and a number of non-expressed ‗silent‘ pilS genes results in a 
change in the pilE sequence. These variants differ in their transformability, 
adherence and immunogenicity  (Virji et al., 1992). Additionally, N. 
meninigitidis spp. possess host specific iron acquisition systems and 
numerous immune evasion mechanisms such as factor H binding protein 
that is able to down-regulate complement deposition (Virji, 2009). Close 
adhesion and invasion is mainly mediated by an array of proteins such as 
opacity proteins (Opc, Opa) and other adhesins. These proteins are believed 
to be responsible for the host specificity as well as for tissues within the 
host (Virji, 2009). Numerous additional apparently minor adhesins (several 
of which were identified by homology searching of the available genomes) 
are generally expressed at low levels during in vitro growth but may be 
important in in vivo infections. Their expression can in fact be regulated at 
different levels in the different environment the bacterium encounter during 
its infection. It has been reported, for example that in conditions that mimic 
the host infection such as iron (Delany et al., 2006) and oxygen limitation 
(Bartolini et al., 2006) or interaction with epithelial cells (Dietrich et al., 
2003) and blood (Echenique et al, in press) the transcriptome of N. 
meningitidis is considerably altered and, as a result, some virulence factors 
may be over-expressed. Furthermore, several adhesins are subject to 
antigenic variation and/or phase variation, which allow bacteria to generate 
a broad and variable repertoire of surface structure that facilitates evasion 
of immune effectors mechanisms and adaptation to different niche (Virji, 
2009). 
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1.5 Adaptation to the host environment 
N. meningitdis, during its infection, is subjected to constant selective 
pressures and its ability to adapt rapidly to environmental changes is 
essential for its survival (Hill et al., 2010). Phase and antigenic variation of 
a number of surface components permits immune evasion during infection, 
but since the bacterium can infect diverse sites within the human host, 
which represent a unique niche with respect to nutrients, environmental 
factors and competing microorganisms, it has to rapidly change its 
metabolism and cellular composition to adapt to different environments. 
Much of this adaptation is carried out at the transcriptional level. Different 
transcriptional regulators, activated by different stresses encountered during 
infection, regulate the transcription of many genes important for survival 
and virulence. However, only few transcriptional regulators are found in the 
pathogenic Neisseria (menigitidis and gonorrhoeae): 35 putative regulators 
in N. meningitidis MC58 strain, compared to Escherichia coli, which 
harbours more than 200 transcriptional regulators. This reveals a striking 
limitation for transcriptional regulation, which is possibly related to the 
restricted ecological niche of the Neisseriacae (Schielke et al., 2010). The 
mechanisms of adaptation of N. meningitidis to two different conditions it 
encounters during infection are described below.  
Iron limitation 
It has been very well established that bacterial pathogenesis and survival 
are dependent on the ability to acquire iron within the host (Andrews et al., 
2003; DeVoe, 1982). Cell growth and multiplication, in fact, require 
essential nutrients such as iron, which is limiting in the human host being 
sequestrated by human iron proteins. Although N. meningitidis does not 
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produce siderophores for iron acquisition, it possesses outer membrane 
receptors that have been postulated to scavenge the iron-loaded 
siderophores secreted by other bacteria colonizing the nasopharyngeal tract 
(Carson et al., 1999). Once inside the host, the organism must compete for 
iron with host iron proteins, and meningococcus possesses receptors for 
transferrin, lactoferrin, and hemoglobin (Perkins-Balding et al., 2004). 
However, iron overload results in toxicity for the bacterium; therefore, iron 
uptake is tightly regulated and in menigococcus, as in many bacteria, this 
regulation is mediated by the ferric uptake regulator (Fur) protein (Delany 
et al., 2003; Escolar et al., 1999). Fur senses internal iron concentration and 
binds to and represses iron uptake genes using ferrous iron as a co-repressor 
(Delany et al, 2003). Fur has been also reported to act positively in the 
expression of certain genes, both with a direct mechanism (binding 
upstream promoter sequences (Delany et al., 2004) and an indirect 
mechanism which involves a posttranscriptional regulation mediated by a 
Fur repressed small regulatory RNA named NrrF (Mellin et al., 2007; 
Metruccio et al., 2009). The regulatory circuit of NrrF is a part of this thesis 
work. 
Oxygen limitation  
During its infection N. meningitidis encounters numerous complex 
extracellular and intracellular environments, since it moves from the upper 
respiratory tract, to mucous membranes, blood and CSF (Archibald & 
Duong, 1986), being exposed to highly divergent partial pressures of 
oxygen (high in the upper respiratory tract and low in the mucus 
membranes and in the blood (Archibald & Duong, 1986). It has been shown 
that although N. meningitidis fails to grow under strictly anaerobic 
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conditions, under oxygen limitation the bacterium expresses a 
denitrification pathway system that supplement growth (Anjum et al., 2002; 
Rock & Moir, 2005). Pathogenic Neisseria use FNR as a global 
transcription factor, to control these responses under oxygen limitation, in 
particular to induce the denitrification and sugar fermentation pathways 
(Bartolini et al, 2006) as an alternative to aerobic respiration. FNR is only 
active as a dimer containing [4Fe-4S] cluster. The cluster dissociates in the 
presence of oxygen, destabilizing the dimer, with loss of FNR activity 
(Kiley & Beinert, 2003). Only a total of 9 transcriptional units have been 
identified as being responsive to the FNR regulator in N. meningitidis 
(Bartolini et al, 2006). Interestingly factor H binding protein (fHBP,) which 
enables the bacterium to evade complement-mediated killing by binding 
factor H (Madico et al., 2006; Schneider et al., 2006), and which is a 
component of the MenB vaccine currently in development, has been shown 
to be positively regulated by oxygen limitation through a FNR dedicated 
promoter (Oriente et al., 2010). This result, together with the observation 
that a knock-out of FNR in N. menigitidis is attenuated in the mouse and 
infant rat animal models (Bartolini et al, 2006), indicate the importance of 
these responses for the pathogenesis and the survival of meningococcus in 
the human host. The identification and analysis of a novel sRNA induced 
under oxygen limitation by FNR is a part of this thesis work. 
 
1.6 Small regulatory RNAs  
Small regulatory RNAs (sRNAs) are crucial regulatory elements in 
bacterial stress responses and virulence (reviewed in: (Gottesman, 2004), 
(Waters & Storz, 2009), (Papenfort & Vogel, 2010). These regulators 
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mostly function as coordinators of adaptation processes in response to 
environmental changes, integrating environmental signals and controlling 
target gene expression, primarily at posttranscriptional levels (Wassarman, 
2002), Gottesman, 2004). Regulatory RNAs can modulate transcription, 
translation, mRNA stability and DNA maintenance or silencing (Waters & 
Storz, 2009). They can act using diverse mechanisms, including changes in 
RNA conformation, protein binding, base pairing with others RNAs and 
interaction with DNA. There are different classes of sRNAs classified 
according to their mechanism of action in bacterial cells. One class of 
sRNA comprises riboswitches. They are sequences at the 5‘ end of mRNAs 
they regulate that can adopt different conformations in response to 
environmental changes, (Grundy & Henkin, 2006) regulating in this way 
the expression of the coding sequence. Another class of sRNAs can bind to 
proteins, including global regulators, and antagonize their function (Pichon 
& Felden, 2007). A recently discovered group of RNA regulators, named 
CRISPR (clustered regulatory interspaced short palindromic repeats) 
provide resistance to bacteriophage (Sorek et al., 2008) and prevent plasmid 
conjugation (Marraffini & Sontheimer, 2008) . CRISPR RNAs contain 
short regions of homology to bacteriophage and plasmid sequences and can 
interfere with bacteriophage infection and plasmid conjugation, most likely 
by targeting the homologous foreign DNA. But the largest and most studied 
group of sRNA, which is also analyzed in this thesis, acts through base 
pairing with mRNAs, modulating their translation and stability. This class 
of regulatory RNAs has two distinct broad classes: the cis enconed sRNAs 
(Fig 4A), that have a perfect complementarity with their targets and the 
trans encoded (Fig 4B) ones, which undergo base-pairing through regions 
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of partial complementarity and may have many distinct mRNA targets. The 
binding of sRNAs to target mRNAs is very specific: a single base 
substitution in the sRNA or target mRNA can be sufficient to disrupt 
duplex formation. Although sRNAs binding is very specific, each sRNAs 
can act on more than one target mRNA and each target mRNA can be 
regulated by multiple sRNAs ( reviewed in (Repoila & Darfeuille, 2009). 
RNA base-pairing interactions are usually in the 5‘ UTR of the target 
mRNA and have been shown to alter mRNA structure ultimately leading to 
changes in translation efficiency and, as a consequence, mRNA stability 
(Wassarman, 2002, Waters & Storz, 2009). It has recently been shown that 
sRNAs can also interact with coding regions, regulating their targets not by 
translational control, but by accelerating RNase E-dependent mRNA targets 
decay (Pfeiffer et al., 2009). The majority of the regulation by the known 
trans-encoded sRNAs is negative (Aiba, 2007; Gottesman, 2004); base 
pairing with the target mRNA usually leads to repression of protein levels 
through translational inhibition, mRNA degradation or both (Sharma et al., 
2007; Vecerek et al., 2007; Morita et al., 2006). However sRNAs can also 
activate expression of their target mRNAs. Base pairing of the sRNA 
disrupt an inhibitory secondary structure, which sequesters the ribosome 
binding site (Hammer & Bassler, 2007; Urban & Vogel, 2008; Prevost et 
al., 2007); Soper et al., 2010).  
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Figure 4 Gene regulation mediated by regulatory RNAs which act by base-pairing (Waters & 
Storz, 2009) 
(A) Two possible configurations of cis-encoded antisense sRNAs (red) and their target RNAs 
(blue), which share extensive complementarity. (Left panel). A sRNA encoded opposite to 
the 5‘UTR of its target mRNA. Base pairing inhibits ribosome binding and often leads to 
target mRNA degradation. (Right panels) A sRNA encoded opposite to the sequence 
separating two genes in an operon. Base pairing of the sRNA can target RNases to the region 
and cause mRNA cleavage, with various regulatory effects, or the sRNA can cause 
transcriptional termination, leading to reduced levels of downstream genes. 
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(B) Genes encoding trans-encoded antisense sRNAs (red) are located separately from the 
genes encoding their target RNAs (blue) and only have limited complementarity. Trans-
encoded sRNA can act negatively by base pairing with the 5‘UTR and blocking ribosome 
binding (left panel) and/or targeting the sRNA-mRNA duplex for degradation by RNases 
(middle panel). Trans-encoded sRNA can act positively by preventing the formation of an 
inhibitory structure, which sequesters the ribosome-binding site (RBS) (right panel). 
 
However two recent papers suggest that in Clostridium and Streptococcus 
the VR-RNA and FasX sRNAs, exert positive regulation of virulence genes 
primarily at the level of mRNA stabilization (Obana et al., 2010; Ramirez-
Pena et al., 2010) and reviewed in (Podkaminski & Vogel, 2010). Those 
sRNAs for which a function has been elucidated are involved in many 
different cellular processes including, adaptation and resistance to stresses 
(Repoila et al., 2003), metabolism and homeostasis (Bejerano-Sagie & 
Xavier, 2007; Masse et al., 2007), control of the expression of outer 
membrane proteins (Vogel & Papenfort, 2006), virulence and pathogenesis 
(Johansson & Cossart, 2003; Romby et al., 2006; Toledo-Arana et al., 
2007). The trans-acting antisense class of sRNAs often require the RNA 
chaperone Hfq as a cofactor, which facilitates the interaction between 
sRNAs and target mRNAs (Valentin-Hansen et al., 2004; Aiba, 2007; Chao 
& Vogel, 2010) (Fig 5). The binding of Hfq can affect the structure of 
sRNA and target mRNAs (Moller et al., 2002; Zhang et al., 2002; 
(Geissmann & Touati, 2004) and Hfq has been demonstrated to accelerate 
strand exchange to facilitate dynamic RNA-RNA interactions (Arluison et 
al., 2007); furthermore Hfq protects many sRNAs from degradation, most 
likely by binding to RNase E cleavage sites within these sRNAs (Moll et 
al., 2003).  
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Figure 5: Mechanisms by which Hfq might facilitate sRNA-mRNA basepairing. (Storz et 
al., 2004) 
Hfq (aqua ring) may promote RNA unfolding or may increase the local concentrations of 
the sRNA (red) and its mRNA target (blue). 
 
1.7 The pleiotropic regulator Hfq 
Hfq is a hexameric RNA binding protein which was originally identified in 
E. coli as a host factor required for the replication of Qbacteriophage 
(Kajitani & Ishihama, 1991). It shares structural and functional homology 
with the Sm proteins in eukaryotes, which have central roles in RNA 
metabolism (Pannone & Wolin, 2000). It has more recently been described 
as a pleiotropic regulator that modulates the stability or translation of an 
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increasing number of mRNAs (Valentin-Hansen et al, 2004; Aiba, 2007; 
(Brennan & Link, 2007) and facilitates pairing of sRNAs with their target 
mRNAs (Moller et al., 2002; Kawamoto et al., 2006); Zhang et al., 2002). 
Available structural data, the latest showing E. coli Hfq bound to 
polyriboadenilate RNA (Link et al., 2009), suggest that Hfq acts as an RNA 
chaperone by binding sRNAs and mRNAs (Fig 6).  
 
 
 
 
 
 
 
 
Figure 6. Structures of the S. aureus Hfq and an Hfq–RNA complex. (Valentin-Hansen et al, 
2004) 
(A) Structure of the Hfq hexamer with each subunit coloured differently. 
(B) Ribbon diagram of an Hfq subunit. The Sm1 motif is coloured blue and the Sm2 motif is 
green. Regions outside the two motifs, i.e. the N-terminal -helix and the variable region, are 
colored yellow.  
(C) Electrostatic surface representation of the RNA binding site of the Hfq hexamer. Blue is 
electropositive and red is electronegative. The RNA is shown as a stick model, with oxygen, 
nitrogen, carbon and phosphorus atoms colored red, blue, white and yellow respectively.  
 
It has been shown that Hfq binds with greater avidity to RNA sites 
containing a short-single stranded stretch of uridines and adenosines 
(Brennan & Link, 2007; Brescia et al., 2003; Mikulecky et al., 2004; Sun & 
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Wartell, 2006). The Hfq protein is conserved in a wide range of bacteria 
and varies in length from 70 to 100 amino acids (Valentin-Hansen et al, 
2004) (Fig 7). In all cases, the Sm motif is located in the N-terminal region 
of the molecule. The C-terminal domain seems not to play a significant role 
in the major functions of Hfq. In fact, a C-terminal truncated form of the E. 
coli Hfq lacking the last 27 amino acids can replace all tested functions of 
the intact E. coli Hfq (102 amino acid residues) (Sonnleitner et al., 2002). 
To date, Hfq candidates have been identified in about half the completed or 
nearly completed bacterial genomes. Two distinct copies are found in few 
species, including Bacillus anthracis and Ralstonia sp., and tandem Hfq 
sequences are present within a single 193-residue protein from 
Novosphingobium aromaticivorans (Sun et al., 2002). Hfq can also 
modulate the decay of some mRNAs  (e.g. rpsO, which encodes for 
ribosomal protein S15) by binding to their poly(A) tails, stimulating 
poly(A) adenylation by poly(A) polymerase I (PAP I) and protecting this 
message from polynucleotide phosphorylase (PNP), RNase II and RNase E, 
enzymes involved in mRNA degradation (Hajnsdorf & Regnier, 2000); 
(Mohanty et al., 2004; Folichon et al., 2005, Folichon et al., 2003). It has 
been shown that Hfq can also protect many sRNAs from degradation, most 
likely by binding to RNase E cleavage sites within these sRNAs (Moll et 
al., 2003). However, recently it has been demonstrated that in Rhodobacter 
sphaeroides the sRNA RSs0019 is stabilized in the absence of Hfq 
(Berghoff et al., 2009) and also in this thesis we provide evidences for a 
sRNA being more stable in hfq of meningococcus. Based on the literature 
the contribution of Hfq to sRNA stability is controversial. While it has been 
shown that the binding of this chaperone, in the absence of basepairing, 
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stabilizes sRNAs protecting them form RNAseE cleaveage (Moll et al., 
2003, Masse et al., 2003); it has also been shown that Hfq-mediated pairing 
of sRNAs to their targets promotes coupled degradation of the interacting 
RNAs (Masse et al., 2003). So it could be possible that binding of Hfq to a 
particular sRNA can accelerate its turnover. 
Considering the role of Hfq as a pleiotropic regulator in bacteria it is not 
surprisingly that the inactivation of the hfq gene results in sensitivity to a 
wide number of environmental stresses and alters the synthesis of many 
proteins, including outer membrane porins (Muffler et al., 1997; Sittka et 
al., 2007; Tsui et al., 1994; Valentin-Hansen et al., 2007). Hfq also 
influences the fitness and virulence of many pathogenic bacteria. Mutants 
lacking Hfq are often sensitive to host defence mechanisms and highly 
attenuated in animal models (Ding et al., 2004; Kulesus et al., 2008; 
McNealy et al., 2005; Sittka et al, 2007; Pichon & Felden, 2005; 
Sonnleitner et al., 2003). Interestingly, in N. menigitidis by signature-
tagged mutagenesis hfq was identified as one of 73 genomic loci that 
attenuated N. menigitidis virulence in rats (Sun et al., 2000). In this thesis 
we show that in N. meningitidis Hfq plays a major role in adaptation to 
stresses and virulence and by a transcriptome study we identified 152 Hfq-
regulated genes which suggest the presence of Hfq-dependent sRNAs 
circuits in this bacterium. Indeed the meningococcal Hfq protein was shown 
to interact specifically with many sRNAs when expressed in the 
heterologous system Salmonella typhimurium (Sittka et al., 2009) 
suggesting that the meningococcal protein has a conserved major function 
as a sRNA-binding protein. To date, virulence phenotypes of hfq mutants 
are most dramatic in Gram-negative pathogens. The role of Hfq in Gram-
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positive species is still under investigation. It has been reported, in fact, that 
hfq strains of L. moncytogens and S. aureus have wild type sRNA profiles 
(Christiansen et al., 2004; Bohn et al., 2007), but the conservation of key 
aminoacids (Valentin-Hansen et al, 2004) and the proven role in antisense 
regulation (Nielsen et al., 2010) suggest the functional conservation of Hfq 
in such species. We can speculate that transcriptional regulation by sRNAs 
can occur by both Hfq-dependent and independent mechanisms. It is not 
still understood if Hfq-independent trans-acting sRNAs can act on their 
own (depending on the free energy for sRNA-mRNA pairing interaction 
(Jousselin et al., 2009), or if they depend on other factors that substitute the 
Hfq protein.  
 
 
 
 
 
 
 
 
 
Figure 7: The Hfq family (Sauter et al., 2003) 
The organisms corresponding to the sequences are indicated on the left. Conserved polar, 
basic and acidic residues appear in green, pink and violet, respectively, Gly and Pro in 
yellow, and a star indicates those involved in RNA binding in S.aureus (Schumacher et al., 
2002). Blue boxes are conserved patches of hydrophobic residues. The 2D structure 
prediction from Jpred is indicated at the bottom as well as the 2D features seen in 3D 
structures.  
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1.8 How to identify new sRNAs  
It is very well established that sRNAs play critical regulatory roles in many 
bacterial processes (reviewed in (Zhou & Xie, 2011; Beisel & Storz, 2010; 
Liu & Camilli, 2010; Toledo-Arana et al., 2007; Repoila et al., 2003). 
However, unlike regulatory proteins, non-coding regulatory sRNAs have 
not been readily identified and annotated in the bacterial genome sequences 
that are available in the databases, and in many systems, including 
Neisseria spp., their existence is still largely unexplored. For this reason 
experimental strategies have become increasingly important for sRNAs 
discovery. The first sRNAs were discovered about four decades ago 
fortuitously using genetic screens, or through radiolabeling of total RNA 
and subsequent isolation from gels (Wassarman et al., 1999). But it was 
only very recently that many new sRNAs have been identified and 
characterized in a wide range of bacterial species. This was mainly possible 
thanks to the increased availability of novel technologies such as 
computational predictions of sRNAs, tiling arrays and high-throughput 
cDNA sequencing (RNA-seq) that are used to study sRNAs at the genome-
wide level (Sharma & Vogel, 2009). The last two techniques not only allow 
the identification of novel sRNAs, but also the analysis of the whole 
transcriptome of bacteria in different growth conditions.  The high density 
(tiling) arrays carry up to hundreds of thousands of DNA oligonucleotides 
systematically covering the sense and antisense strand of a genome, 
including the intergenic regions (IGRs) from which most known sRNAs are 
expressed. An important issue in this kind of technique, as well as the 
RNA-seq, is choosing physiological conditions in which sRNAs are 
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expressed. Genomic tiling arrays have been successfully used to study the 
transcriptome of Listeria monocytogenes (Toledo-Arana et al., 2009), 
Bacillus subtilis (Rasmussen et al., 2009) and Mycoplasma pneumoniae 
(Guell et al., 2009), as well as specific genomic features in E. coli (Selinger 
et al., 2000) and Caulobacter crescentus (McGrath et al., 2007). However, 
the array-based approach requires hundreds of thousands probes and is 
limited by background noise and cross hybridization, and therefore requires 
extensive normalization (Sorek & Cossart, 2010). In contrast to microarray 
methods, RNA-seq directly determine the cDNA sequence. This technique 
uses recently developed deep-sequencing technologies. In general, a 
population of RNA is converted to a library of cDNA fragments with 
adaptors attached to one or both ends. Each molecule, with or without 
amplification, is then sequenced in a high-throughput manner to obtain 
short sequences. The reads are typically 30–400 bp, depending on the 
DNAsequencing technology used. To generate a transcriptome map, these 
reads are computationally mapped to the reference genome (Fig 8).  
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Figure 8: A typical RNA-seq experiment. (Wang et al., 2009) 
Briefly, long RNAs are first converted into a library of cDNA fragments through either 
RNA fragmentation or DNA fragmentation. Sequencing adaptors (blue) are subsequently 
added to each cDNA fragment and a short sequence is obtained from each cDNA using 
high-throughput sequencing technology. The resulting sequence reads are aligned with the 
reference genome or transcriptome and used to generate a base-resolution expression 
profile. In principle, any high-throughput sequencing technology can be used 
for RNA-Seq (Wang et al, 2009), and the Illumina, Applied Biosystems 
SOLiD and Roche 454 Life Science systems have already been applied for 
this purpose in bacteria (Passalacqua et al., 2009; Perkins et al., 2009; Sittka 
et al., 2008; Yoder-Himes et al., 2009; Wurtzel et al., 2010). An important 
 34 
advantage of RNA-Seq is that it has very low, if any, background signal 
because DNA sequences can been unambiguously mapped to unique regions 
of the genome. A transcriptome analysis can be used to improve genome 
annotation by enabling: the discovery of new genes, the correction of gene 
annotation; the detection of UTRs and transcription start sites and the 
determination of operon relationship (Sorek and Cossart, 2009 and Fig 9). 
Furthermore, whole-transcriptome analysis now allows the global 
interrogation of sRNA abundance and antisense RNAs in any species 
primarily by detecting expression from non-protein-coding regions. In this 
way, for example, 13 sRNAs that were induced during niche switching in 
the opportunistic pathogen B. cenocepacia were recently discovered (Yoder-
Himes et al, 2009). Similarly, Perkins et al. detected 55 intergenic regions 
that are likely to encode new sRNAs in Salmonella Typhi Ty2 (Perkins et 
al, 2009), and the number of known sRNAs in L. monocytogenes has been 
more than doubled to 50 sRNAs by a tiling arraybased study (Toledo-Arana 
et al., 2009). Interestingly, sRNAs can also be enriched by co-
immuoprecipitation with the Hfq protein (Zhang et al., 2003; Stikka et al, 
2008) and subsequently sequenced. In conclusion, with whole-transcriptome 
analysis it is now possible to study the involvement of elements such as 
sRNAs, riboswitches and cis-antisense regulators in the physiology and 
pathogenicity of any prokaryote. 
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Figure 9: Different applications of RNA-seq (Sorek & Cossart, 2010) 
The x axis represents a schematic genomic region and the y axis represents transcript 
coverage as derived from RNA-seq. The light blue arrows depict annotated genes. 
Transcriptomic information can be used to improve genome annotation by enabling: the 
discovery of new genes or sRNAs (a); the correction of gene structure annotations (b); the 
black M depicts the predicted first methionine and the red M is the first methionine in the 
corrected annotation); the detection of UTRs and transcription start sites (c); and the 
determination of operon relationships (d). 
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RESULTS 
 
I. Characterization of a hfq knock out mutant in Neisseria 
meningitidis 
 
1.9 The hfq locus of N. meningitidis 
In N. meingitidis, the hfq gene (NMB0748) is predicted to encode
 
a protein 
protein of 97 amino acids and shows 65% identity
 
with the Hfq protein 
from E. coli. In the MC58 genome
 
hfq is flanked upstream by a 147-bp 
intergenic region possibly
 
containing its promoter and is followed 
downstream by a putative
 
transcriptional terminator (Fig. 10A). This is in 
contrast to
 
E. coli and other similar enterobacteria, in which hfq appears
 
to 
be located in a cluster of genes which form an operon, usually
 
transcriptionally linked to the upstream gene miaA (Tsui et al., 1994). We 
mapped the promoter of the hfq gene of N. meningitidis in
 
the intergenic 
region directly upstream by performing S1 nuclease
 
protection analysis. 
Total RNA was isolated from the MC58 strain
 
during in vitro growth and 
then hybridized with a hfq-specific
 
probe and digested with S1 nuclease. 
Figure 10B shows an RNA-protected
 
band which corresponds to the 5' end 
of the hfq mRNA, which
 
maps the transcriptional initiation site (+1) to 49 
nucleotides
 
upstream of the ATG start site of the gene. Analysis of the
 
nucleotide sequence upstream revealed –10 (TACAAT) and –35 
(TGGATA) hexamers, suggesting that the hfq gene is transcribed from a 
70 promoter. The intensity of this band does not vary significantly in RNA 
prepared from various time points
 
in the growth curve, suggesting that the 
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hfq promoter is transcribed constitutively
 
throughout the various growth 
phases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: The hfq locus of N. meningitidis. (A) Diagram of the hfq locus in the genome of 
N. meningitidis strain MC58, showing the strategy used to construct the hfq null mutant by 
allelic replacement with a chloramphenicol cassette. The genes flanking the hfq gene in 
meningococcus are an upstream gene encoding a putative D-alanine-endopeptidase and a 
downstream gene encoding a conserved hypothetical protein with homology to RNA 
methylases. These genes are different from genes in other Gram-negative and Gram-
positive bacteria in which a similar genetic organization has often been observed. In the 
sequence of the intergenic region upstream of the hfq gene underlined bold type indicates -
10 and -35 hexamers and the transcriptional start site at position +1, as shown in panel B. 
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The sequence of the putative rho-independent transcriptional terminator and its position 
with respect to the initiation of transcription at position +1 are also shown. (B) Mapping of 
the hfq promoter by an S1 nuclease protection assay. The DNA probe was radioactively 
labeled at one end, hybridized to 15 g of total meningococcal RNA (lanes T1, T2, T3, T5, 
and T7), and digested with S1 nuclease for mapping of the 5‘ end of the hfq transcript. 
Total RNA was prepared after 1, 2, 3, 5, and 7 h of growth in GC broth (lanes T1, T2, T3, 
T5, and T7, respectively). Two control samples with E. coli tRNA instead of total RNA 
were processed in parallel with (lane +) and without (lane -) addition of S1 nuclease. The 
position of the RNA-specific S1 nuclease-protected band corresponding to the 5‘ end of the 
hfq transcript is indicated. Lane G+A contained a G-A sequence reaction mixture for the 
DNA probe used as a size marker. The nucleotide sequence of the coding strand upstream 
of the transcriptional start site is shown on the left. 
 
 
1.10 Expression of the meningococcal Hfq protein and 
generation of an Hfq null mutant 
In order to investigate the expression of the Hfq protein in the
 
MC58 strain, 
we purified the Hfq protein and raised antibodies
 
to Hfq in mice. We cloned 
the hfq gene into an expression vector,
 
expressed it as a recombinant His-
tagged protein in E. coli,
 
and then purified it by Ni-NTA affinity 
chromatography. Figure
 
11A shows the results of an SDS-PAGE analysis of 
various fractions
 
obtained for the expression and purification steps. The Hfq
 
protein was highly expressed in the soluble fraction (Fig. 11A,
 
lane 3) and 
gave rise to a highly pure recombinant His-Hfq protein
 
preparation (lanes 6 
to 8), and the N-terminal His tag was cleaved
 
and removed after 
purification, giving rise to an untagged Hfq
 
protein (lane 9). Using in vitro 
cross-linking, we investigated
 
whether this protein oligomerized into its 
functional hexameric
 
form. As Fig. 11B shows, after treatment for 1 h with 
the DSS
 
cross-linker, two high-molecular-weight oligomers were visible
 
on 
the gel. One of the major cross-linked forms migrated at
 
a molecular weight 
 40 
of approximately 70,000, which is consistent
 
with the hexameric form of 
the protein, and the other more slowly
 
migrating form may represent two 
cross-linked hexamers, suggesting
 
that the recombinant Hfq protein forms 
hexamers in solution.
 
This protein preparation was used to raise antibodies 
against
 
meningococcal Hfq in mice, and the resulting antiserum was tested
 
in an immunoblot analysis with total protein samples taken from
 
time 
course cultures of the MC58 strain and an Hfq null mutant
 
strain.  
 
Figure 11 : (A) Expression and purification of the recombinant Hfq protein. SDS-PAGE 
was performed with protein extracts from uninduced (lane -) and IPTG-induced (lane +) 
cultures of E. coli containing the pET15bHfq expression plasmid, the cleared soluble 
fraction before (lane SF) and after (lane FT) binding to the Ni-NTA resin, the wash fraction 
(lane W), elution fractions (lanes E1 to E3), and untagged Hfq protein after thrombin 
digestion (lane Dig). (B) In vitro cross-linking of Hfq reveals hexameric forms in solution. 
For in vitro cross-linking, the untagged protein was not treated (lane -) or treated (lane +) 
with the cross-linking reagent DSS. The relative positions of the molecular weight markers 
(lane M) are indicated on the left. The positions of the oligomeric forms of the Hfq protein 
are indicated on the right. (C) Western blot showing the expression of the Hfq protein in 
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wild type strain MC58 or the hfq mutant over time. Total protein samples were taken at 
the time points shown in Fig. 12A. Five micrograms of total protein was loaded for each 
time point. Anti-Hfq antiserum recognizes a band at approximately 11 kDa in the wild type 
strain but not in the Hfq null mutant. Antiserum against NMB2091 was also used to stain 
the blot as a loading control for total protein, as indicated by the asterisk. 
 
 
The null mutant of MC58 was generated by replacing the hfq gene
 
with a 
chloramphenicol cassette, as indicated in Fig. 10A. This
 
mutant, when it is 
grown on solid medium, has an obvious growth
 
phenotype in that it forms 
small pinpoint colonies after overnight
 
incubation. Furthermore, after 
approximately 2 to 3 days of
 
growth on solid medium, the centers of the 
colonies have a concave
 
morphology, and, where there is confluent growth 
on the plate,
 
the culture appears to be more flat and acquires a silver sheen.
 
We grew the wild type and null mutant in liquid GC medium and
 
took 
samples every hour over the time course. Consistent with
 
the growth 
phenotype on plates, the null mutant exhibited a
 
significantly altered growth 
curve compared with the wild type
 
in liquid medium (Fig. 12A). In 
particular, it had an increased
 
lag phase and did not reach a cell density 
equivalent to that
 
of the wild type. Western blot analysis of the expression 
of
 
Hfq throughout the time course (Fig. 11C) revealed that the anti-Hfq
 
antiserum recognizes a protein band migrating to a position
 
corresponding 
to approximately 11 kDa in the wild type, which
 
is absent from the null 
mutant strain. Furthermore, the protein
 
is expressed during all phases of the 
growth curve, which is
 
consistent with results shown in Fig. 10B, and no 
significant
 
differences in the level of expression were detected, except
 
possibly for slight accumulation of the protein in late log
 
and stationary 
phases. 
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1.11 Complementation of the Hfq mutant. 
In order to investigate downstream polar effects due to the
 
hfq mutation, we 
performed RT-PCR analysis of the NMB0747 gene
 
using RNA prepared 
from the wild type and the Hfq knockout mutant.
 
The results showed that 
there was a 10-fold reduction in RNA
 
levels for NMB0747, indicating that 
readthrough of the putative
 
rho-independent terminator occurs and that it is 
likely that
 
hfq is coexpressed with the downstream gene. In order to 
determine
 
if the phenotypes of the mutant were directly related to the
 
lack 
of expression of the Hfq protein or possible polar effects,
 
we generated a 
complemented mutant strain expressing a single
 
copy of the hfq gene in 
trans and related this expression to
 
possible restoration of the wild type 
phenotype. In this strain,
 hfq_C, the expression of the hfq gene was 
inducible
 
by addition of IPTG, as its transcription is under the control
 
of the 
Ptac promoter and the LacI repressor. This strain was
 
grown in liquid 
cultures in the presence of increasing amounts
 
of IPTG, along with the wild 
type and mutant strains, and the
 
growth curves are shown in Fig. 12A. 
Samples were collected at
 
mid-log phase, and total protein extracts of each 
strain were
 
used to monitor Hfq expression by Western blotting (Fig. 12B).
 
The generation time of the mutant was significantly less (78
 
± 10 min) than 
that of the wild type (48 ± 7 min),
 
while the generation times of the 
complemented mutant were shorter
 
in cultures with IPTG-induced increases 
in Hfq expression. It
 
is worth noting that the levels of Hfq expression in the 
complementing
 
strain at the time of maximal induction were approximately 
two-
 
to threefold less than the wild type levels, and this may explain
 
the 
incomplete restoration of the growth phenotype. These results
 
indicate that 
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the growth defect of the hfq mutant can be restored by expression of Hfq 
in a dose-dependent manner. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 : (A) Growth curves for the wild type, the hfq mutant, and the hfq_C 
complemented mutant in GC medium supplemented with different concentrations of IPTG 
(in M, as indicated after the mutant designation). Three independent sets of cultures were 
grown on different days, and the symbols indicate the average of the three cultures for each 
strain; the error bars show the standard deviations. The calculated generation times of the 
cultures were as follows: MC58, 48 ±7 min; hfq, 78 ±10 min; and hfq_C with 0, 1, 10, 
100, and 1,000 _M IPTG, 80 ± 5, 80 ± 5, 70 ± 17, 55 ± 8, and 51 ± 10 min, respectively. 
(B) Western blotting of cell lysates of the MC58 wild type strain, the hfq mutant, and the 
complemented mutant, showing Hfq expression. IPTG was added at the final 
concentrations indicated to the growth medium for induction of Hfq in the complemented 
mutant. Cells were grown in GC broth to an OD600 of 0.5, and 10 g of total protein was 
added to each lane. 
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1.12 Hfq plays a major role in stress tolerance in N. 
meningitidis. 
As Hfq is reported to be involved in stress tolerance in many pathogens
 
(Christiansen et al., 2004; Robertson & Roop, 1999; Schiano et al., 2010; 
Meibom et al., 2009) and a large number of proteins are differentially
 
expressed in the hfq mutant, we tested the ability of the meningococcal 
hfq mutant to resist several environmental stresses. A series of growth 
assays and killing assays were performed with the
 
wild type, the hfq 
mutant, and the hfq_C complemented mutant strain in the presence of 
different antimicrobial compounds. The hfq mutant was significantly more 
sensitive than the wild type
 
strain to three membrane-perturbing detergents 
(the nonionic
 
detergents Triton X-100 and Tween, as well as the anionic 
detergent
 
SDS), and the results of a representative viability assay are
 
shown 
in Fig. 13A. Likewise, the lack of expression of the hfq
 
gene resulted in 
increased sensitivity of the null mutant strain
 
to killing by oxidative stress, 
as investigated using paraquat
 
(which generates superoxide anion radicals 
inside the cell),
 
xanthine-xanthine oxidase (which generates superoxide and 
H2O2
 
outside the cell), and H2O2 assays (Fig. 14B). We also challenged
 
the 
strains with 4.5 M NaCl in an osmotic stress assay. Again,
 
the hfq mutant 
was significantly more sensitive than the strains
 
expressing the Hfq protein 
(Fig. 13C). Finally, we tested whether
 
the meningococcal mutant was more 
sensitive to antimicrobial
 
peptides, such as polymyxin B or LL-37. 
Antimicrobial peptides
 
are an important part of the innate immune response, 
which can
 
attack the outer membrane, forming holes and thereby causing
 
misfolding of the periplasmic proteins and envelope stress.
 
The results 
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shown in Fig. 13C indicate that Hfq contributes considerably
 
to resistance 
to antimicrobial peptides in meningococcus. In
 
all assays performed, the 
complemented mutant exhibited resistance
 
patterns very similar to those of 
the wild type (Fig. 13A to C),
 
confirming that inactivation of Hfq results in 
considerable
 
sensitivity of the mutant strain to these antimicrobial 
compounds.
 
The wild type, the mutant, and the complemented mutant all 
behaved
 
similarly when they were incubated for the duration of the assay
 
in 
GC broth, indicating that the differences in survival are
 
not due to intrinsic 
growth defects (data not shown). Based
 
on all these analyses, the Hfq 
protein plays an important role
 
in the resistance of meningococcus to a wide 
range of stresses,
 
many of which may be particularly physiologically 
relevant to
 
the infectious cycle. 
 
1.13 Hfq contributes to the survival of meningococcus in ex 
vivo and in vivo models 
To examine how the strains responded to conditions comparable
 
to those in 
the host, their survival in ex vivo whole-blood
 
and serum assays was 
assessed. The human blood assay was used
 
to assess both cellular and 
humoral mechanisms of killing (including
 
the action of complement, 
antibody-mediated serum bactericidal
 
activity, and opsonophagocytosis, as 
well as killing by neutrophils,
 
macrophages and antimicrobial peptides), 
while the serum assay
 
was used to assess killing of N. meningitidis 
mediated by the
 
humoral immune response. The Hfq mutant was less able 
to survive
 
in human blood and exhibited serum sensitivity (Fig. 14A and B).
 
Once the serum was heat inactivated, the sensitivity of the
 hfq mutant was 
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lost, and the number of CFU did not decrease
 
over the time course of the 
assay, which implies
 
that the hfq mutant is sensitive to a heat-labile 
component
 
of the complement pathway. For in vivo infection studies, an 
isogenic hfq mutant of the
 
adapted 2996 strain was generated for use in the 
infant rat
 
model. Groups of six mice were inoculated intraperitoneally
 
with 
either a high (10
5
 CFU) or low (10
3
 CFU) dose of the wild
 
type or the hfq 
mutant strain. After 18 h, the animals were
 
bled, and bacteria were counted 
by colony plating. Compared
 
to the counts for the wild type strain, the 
bacterial counts
 
for the hfq mutant were significantly decreased (Fig. 
14C). Although
 
we cannot exclude the possibility that the growth phenotype
 
may contribute to the reduced survival in the rat, these results
 
suggest that 
Hfq plays a role in the pathogenesis of meningococcus
 
in ex vivo human 
models and in the in vivo infant rat model. 
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Figure 13: Assays of the viability of wild type strain MC58, the hfq mutant, and the 
hfq_C complemented mutant. Cells were grown to an OD600 of 0.5 in GC broth (1 mM 
IPTG was added for expression of Hfq in the complemented mutant), diluted, and 
incubated with the antimicrobial compounds indicated. Samples were taken at 15, 30, 
and/or 60 min, and viable cell counts were determined by plating. The final concentrations 
of compounds used were as follows: Tween, 0.05%; SDS, 0.01%; Triton X-100, 0.1%; 
hydrogen peroxide, 5 mM; xanthine oxidase, 4.3 mM xanthine and 300 mU xanthine 
oxidase; paraquat, 5 mM; NaCl, 4.5 M; LL-37, 2 M; and polymyxin B, 10 g/ml. 
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Figure 14: Survival of strain MC58, the hfq mutant, and the hfq_C complemented 
mutant in ex vivo whole blood (A) and serum (B) assays and an in vivo infant rat model 
(C). There was a reduced level of bacteremia with the hfq mutant in an infant rat infection 
model. Groups of animals were inoculated with two initial doses (approximately 10
3
 and 
10
5
 CFU; specific levels of the initial inoculum were determined in each case and are 
indicated on the x axis), and bacterial counts for the wild type (diamonds) and the hfq 
mutant (triangles) recovered from the blood of each animal were determined after an 18-h 
period. The P values for comparisons of the levels of the wild type and the hfq mutant 
recovered with initial doses of 10
3
 and 10
5
 CFU are 0.0007 and 0.0057, respectively 
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1.14 Identification of proteins differentially expressed in the 
hfq mutant 
To obtain a preliminary picture of global changes in the expression
 
profiles 
of proteins altered in the hfq mutant, we compared the whole-cell protein 
patterns in SDS-PAGE gels for culture
 
samples obtained at mid-log phase 
(Fig. 15). The lack of Hfq
 
in the mutant results in global changes in protein 
expression,
 
and many protein bands are more abundant or less abundant in
 
the Hfq-deficient strain. Furthermore, the expression profile
 
of the mutant is 
restored to a profile similar to that of the
 
wild type after restoration of Hfq 
expression in the hfq_C strain by IPTG addition. In order to identify some 
of the proteins differentially expressed
 
due to deletion of the Hfq protein, 
total protein from logarithmically
 
grown cultures of wild type and hfq 
mutant cultures were separated
 
by one-dimensional (1D) or 2D 
electrophoresis. Furthermore,
 
cell cultures were also fractionated to obtain 
secreted, cytoplasmic,
 
and envelope fractions and separated by 1D SDS-
PAGE. Representative
 
gels for triplicate samples are shown in Fig. 15, and 
the most
 
altered protein spots and bands that were identified by mass
 
spectrometry are shown in Fig. 15B and C, respectively. These
 
spots and 
bands were excised and digested with trypsin, and
 
the resulting peptides 
were analyzed by MALDI-TOF mass spectrometry.
 
It is worth noting that a 
greater number of high-molecular-weight
 
proteins appeared to be released 
into the supernatants of the
 
hfq mutant cultures than into the supernatant of 
the wild type
 
strain cultures, although many of these proteins could not be
 
identified. Using mass spectrometry analysis following 1D and
 
2D 
separation, we were able to identify 27 proteins that showed
 
altered 
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accumulation in the hfq mutant, and results of these analyses are shown in 
Table 1. Twenty of the proteins appear
 
to be upregulated in the hfq 
mutant, and seven proteins are
 
downregulated. The functions of the proteins 
whose abundance
 
is altered can be subdivided into various groups, 
including
 
energy metabolism, amino acid biosynthesis, oxidative stress
 
responses, and outer membrane proteins (OMPs), many of which
 
are 
associated with pathogenicity. 
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Figure 15 : Identification of differentially abundant proteins in the hfq knockout mutant.  
(A) SDS-PAGE of cell lysates of the MC58 wild type strain, the hfq mutant, and the 
complemented mutant, showing pleiotropic effects of Hfq on protein expression in the hfq 
mutant. The arrows on the right indicate the positions of derepressed protein bands, and the 
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filled circles indicate downregulated protein bands in the hfq null mutant. (B) Total proteins 
of logarithmically grown wild type strain MC58 and the hfq mutant were separated by 2D 
gel electrophoresis. Proteins were first focused on a nonlinear pH 3 to 10 gradient and then 
separated on a 9 to 16.5% SDS-polyacrylamide gel. Cells were grown to an OD600 of 0.5 
in GC broth. (C) 1D SDS-PAGE analysis of total proteins (Total) or cytoplasmic (Cyto) or 
envelope (Env1 and Env2) fractions of cells of the wild type (lane +) and the Hfq mutant 
(lane -) grown to log phase in GC broth. Both 1D and 2D gels were stained with Coomassie 
brilliant blue R-250. In addition, wild type and Hfq mutant cultures were grown to an 
OD600 of 0.2 in Mueller-Hinton medium containing 0.25% glucose, and 22 ml of cell-free 
supernatant was precipitated and loaded (Supr) 
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Table 1: Deregulated proteins in hfq identified by Mass-SPEC 
Band/Spot Designation (gene) Categor or Protein Name Predicted Function Molecular 
weight 
Relative 
change in 
hfq (fold)a 
Down-regulated proteins 
C1 NMB0758 (pnp) Polyribonucleotide 
nucleotidyltransferase  
RNA metabolism 76374 -3.0 
C2 2D12 NMB1938 (atpA) ATP synthase F1, alpha subunit Energy metabolism: ATP-proton 
motive force interconversion  
55257 -2.4 
C3 NMB1936 (atpB) ATP synthase F1 beta subunit Energy metabolism: ATP-proton 
motive force interconversion 
50360 -2.1 
T1 
C4 
NMB0763 (cysK) Cysteine synthase Amino acid biosynthesis: Serine 
family 
32800 -2.4 
2D13 NMB0335 (dapD) 2,3,4,5-tetrahydropyridine-2,6-
dicarboxylate N-succinyltransferase 
Amino acid biosynthesis: 
Aspartate family 
29391 -2.3 
2D6  NMB0138 (fusA) Elongation factor G (EF-G) Protein synthesis 77408 -1.3 
2D7  NMB0618 (ppsA) Phosphoenolpyruvate synthase Energy metabolism: 
Glycolysis/gluconeogenesis 
Carbohydrate transport and 
metabolism 
87115 
 
-2 
Upregulated Proteins2.3 
T2 E6 E17 2D1 NMB1571.42 (acnB) Aconitase hydratase 2 Energy metabolism: TCA cycle 92657 +2.3 
T3 2D2  NMB0920 (icd) Isocitrate dehydrogenase Energy metabolism: TCA cycle 80113 +1.4 
2D3  NMB0954 (gltA) Citrate synthase Energy metabolism: TCA cycle 48587 +2 
C9 NMB431 (pprC) Methylcitrate synthase Energy metabolism: Propionate 
metabolism 
42792 +2 
2D4  NMB0435 (ackA-1) Acetate kinase Energy metabolism: 
Fermentation  
43336 +1.3 
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E2 
NMB1388 (pgi-2) Glucose-6-phosphate isomerase Energy metabolism:  
Carbohydrate transport and 
metabolism 
62044 +2.9 
2D10 2D11 NMB1796 
 
Conserved hypothetical protein: 
Oxidoreductase 
Energy metabolism: Electron 
transport 
20989 +1.9 
2D8  NMB1584  3-hydroxyacid dehydrogenase Central intermediary metabolism: 
Other 
30359 +3 
E1 2D5 NMB1055 (glyA) Serine hydroxymethyltransferase Amino acid biosynthesis: Serine 
family 
45243 +1.3 
E5 NMB0944 (metH) 5-methyltetrahydropteroyltriglutamate-
homocysteine methyltransferase 
Amino acid biosynthesis: 
Aspartate family 
85024 +1.4 
T7 NMB0946 (prx) Peroxiredoxin 2 family 
protein/glutaredoxin 
Detoxification: Oxidative stress 
reponse 
26894 +1.4 
C5 NMB0884 (sodB) Superoxide dismutase Detoxification: Oxidative stress 
reponse 
21879 +1.7 
C7  NMB1590 Conserved hypothetical protein: 
putative peroxidase 
Unknown function: Oxidative 
stress reponse  
11526 +1.6 
E4, E10 NMB0182 (omp85) Outer membrane protein Omp85 Outer Membrane lipid biogenesis 88382 +1.2
b
 
E14, E15 
 
NMB1053 (opc) Class 5 outer membrane protein  Pathogenesis: Adhesion 29973 
 
+1.3 
 
S10 NMB1053 (opc) 
 
NMB1636 
Class 5 outer membrane protein  
 
Opacity protein 
Pathogenesis: Adhesion 29973 
 
30161 
+2.3 
 
+2.3 
S7  NMB1541 (lbpB) Lactoferrin binding proteinB Transport of iron cations 81082 +1.8 
S11 NMB0634 (fbpA) Iron ABC transporter, periplasmic 
binding pr. 
Transport of iron cations 35806 +1.5 
2D9  NMB0018 Pilin pilE Pathogenesis: Cell motility and 
adhesion 
18202 +1.6 
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            1.15 Global analysis of gene expression in the Hfq null mutant 
In order to investigate, not only protein expression levels, but also global 
transcription profile differences in N. meningitidis expressing or lacking the Hfq 
RNA chaperone we used custom-made Agilent oligonucleotide microarrays. We 
identified in this way differentially expressed genes in the transcriptional profiles 
of the MC58 wild type and hfq null mutant strains. Three independent 2-colour 
microarray experiments were performed comparing pooled RNA from triplicate 
cultures of each strain grown to mid log phase in GC medium. The results obtained 
from these three experiments were averaged after slide normalization and 
differentially expressed genes were identified with a threshold of two-fold 
transcriptional change and a t-test statistics p-value ≤ 0.05. Table 6 indicates the 
average result of the three experiments showing all the genes considered regulated. 
A total of 152 genes were found to be differently regulated, 112 were up regulated, 
and 40 were down regulated, in hfq, suggesting that Hfq acts more often to 
repress rather than to activate gene expression in N. meningitidis. To validate the 
microarray results, RT-PCR was performed on 10 selected genes spanning values 
from the most highly up- to down-regulated and we obtained a good coefficient of 
correlation (0.9422) between the microarray and RT-PCR results (Fig. 16). The 
152 significantly regulated genes can be subdivided into 18 categories based on the 
function of their products, according to the classification of TIGRfams (Haft et al., 
2001) (Table 2).  
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Figure 16 : Quantitave RT-PCR validation of microarray data of the Hfq knock out mutant vs 
MC58 wild type strain. Values plotted represent the log2 ratio in transcript level of 10 genes in 
MC58 vs Δhfq strains. Genes were selected from the most highly up- to  down-regulated. The 
coefficient of correlation obtained is indicated in the graph. 
 
 
Four functional categories are over-represented within the data: cell envelope, 
transport and binding proteins, energy metabolism, and hypothetical proteins. 
These results are in accordance with the proteomic analysis which revealed that the 
expression of a number of OMPs was altered in the hfq mutant (Table 1). 
Furthermore these findings raise the possibility that membrane composition, 
particularly outer, may be regulated by sRNAs in meningococcus as reported for 
other systems (for review see (Vogel & Papenfort, 2006, Valentin-Hansen et al., 
2007, Guillier & Gottesman, 2006)).   
Many metabolic enzymes involved in glycolisis and/or TCA cycle (icd, acnB, 
acnA, gltA, pgi2, fumC) are up-regulated. We cannot exclude that this could be an 
indirect consequence of reduced growth of hfq, but interestingly we can notice 
that prpC, gltA and acnB have been reported in other systems to be under the likely 
 57 
direct control of sRNAs (Oglesby et al., 2008, Masse & Gottesman, 2002). By 
contrast, components of electron transfer chains (fixP, fixO, fixN) are 
downregulated. Since the electron transport chain generates proton motif force 
across the cytoplasmic membrane, this function may be reduced in hfq. 
Interestingly, some subunits of the ATP synthase (atpC, aptD, atpG,) that use this 
energy to generate ATP are also down regulated. 
These experiments identify genes with differential steady state levels of mRNA 
transcripts which could be due to transcriptional (initiation) or posttranscriptional 
(mRNA stability and degradation) effects.  While it is still to be determined 
whether the differential expression is due to direct or indirect effects of Hfq 
function, with this strategy we are able to reveal Hfq-dependent mRNA regulation 
in approximately 7.5% of meningococcal genes in log phase, confirming Hfq as a 
global regulator of gene expression in meningococcus.  
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Functional group Down 
regulated 
Up 
regulated 
Total
  
in 
genome 
%
 
regulated 
genes  
Amino acid biosynthesis 1 1 76 3% 
Biosynthesis of cofactors, 
prosthetic groups, and 
carriers 
1 1 83 2% 
Cell envelope 3 15 239 8% 
Cellular processes 1 5 119 5% 
Central intermediary 
metabolism 
1 1 40 5% 
Disrupted reading frame 1 0 36 3% 
DNA metabolism 0 1 91 1% 
Energy metabolism 11 12 151 15% 
Fatty acid and phospholipid 
metabolism 
0 0 31 0% 
Hypothetical proteins 12 59 664 11% 
Mobile and 
extrachromosomal element 
functions 
0 1 49 2% 
Protein fate 2 0 73 3% 
Protein synthesis 0 5 129 4% 
Purines, pyrimidines, 
nucleosides, and nucleotides 
0 0 43 0% 
Regulatory functions 2 1 56 5.4% 
Transcription 0 0 38 0% 
Transport and binding 
proteins 
5 4 131 7% 
Unknown function 0 6 105 6% 
 
Table 2. Numbers of genes deregulated in the Hfq null mutant during in vitro logarithmic phase in 
the different functional groups according to the classification of TIGRfams. The total number of 
genes in each category and the number of the up or down regulated genes in hfq are indicated. 
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II Identification of AniS: a novel sRNA synthesied under oxygen 
limitation 
 
1.16 NMB1205 is a small transcript deregulated in the Hfq mutant 
NMB1205 is one of the most highly down-regulated genes (4,3 fold change, Table 
6) in the Hfq knock out mutant. In the MC58 genome, NMB1205 is annotated as a 
147 bp hypothetical gene predicted to encode a protein of 48 amino acids of 
unknown function, flanked upstream by the bacterioferritin B and A genes and 
downstream by a transcriptional regulator and a protein-PII uridylyltransferase, all 
in the same orientation (Fig 17A). NMB1205 is not annotated as a paralogous 
coding gene in the other Neisseria genomes, although there is high nucleotide 
sequence conservation at the NMB1205 locus in many of the other genome 
sequences from pathogenic and commensal Neisseria spp. (Fig 17A and B), 
possibly due the absence of a canonical Shine-Dalgarno sequence for the translation 
initiation upstream of the ATG start codon, or the reduced length of the possible 
ORFs in the other strains (data not shown). We performed Northern Blot analysis 
using a radioactively-labeled NMB1205-specific probe on total RNA extracted 
from MC58 and the Hfq knockout. A single band appeared in RNA from the wild 
type strain, absent from the Hfq knockout sample, which migrates with an apparent 
molecular weight of less than 100 nt (Fig 18A). This correlates with the microarray 
data where transcription of NMB1205 was greatly downregulated in hfq. 
Surprisingly, the size of the transcript was considerably shorter than expected. 
We mapped the 5‘ end of the NMB1205 transcript by primer extension analysis 
(Fig 18B). The elongated primer resulted in a double band mapping two tandem 
transcriptional starts at the A (which we nominate +1) and T of the predicted ATG 
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putative start codon of NMB1205. Analysis of the DNA sequence upstream 
revealed the presence of a possible -10 (GATAAT) and weakly conserved -35 
(AATACC) with respect to the E. coli sigma 70 consensus hexamers that are likely 
to define the PaniS promoter. Interestingly, we found a putative FNR-box (TTGAT-
N4-ATCAA) at -41.5 with respect to the transcriptional start (Fig 17B), suggesting 
the promoter to be FNR-regulated. Furthermore, we found a putative rho-
independent terminator of transcription inside the NMB1205 coding region. To 
assess the ability of this sequence to terminate transcription in vitro, we generated 
two different DNA templates for in vitro transcription of the NMB1205 locus 
consisting of a T7 promoter fused to the +1 transcriptional start site and spanning to 
either the end of the predicted terminator (+106) or to the end of the predicted ORF 
(+155). In vitro transcription with the T7 RNA polymerase of the shorter template 
gave rise to a transcript which migrated with an apparent weight of less than 100 nt 
(lane 1, Fig 18C). The reduced length of the transcript may be due to transcriptional 
termination at one of the Us upstream of the terminal U of the terminator. 
Approximately 95% of the transcription reaction from the longer template gave rise 
to a transcript of similar length (less than 100 nt, lane 2), indicating that the 
predicted rho-independent terminator works in vitro with very high efficiency. 
Taking together these results, we conclude that the NMB1205 locus gives rise to a 
short transcript, of approximately 100 nt, that is unlikely to code for a peptide. 
Comparative analysis of this sequence in the available Neisserial genomes from 
diverse species revealed the likely presence of a sRNA paralogue in all the 
genomes which was highly conserved over 56 nt at the 3‘ end (Fig 17B). 
Interestingly although the 5‘ of these sequences is variable in length, the presence 
of conserved regulatory elements of the promoter (FNR-box upstream of a putative 
-10) and the transcriptional terminator suggests that an FNR-regulated small RNA 
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is synthesized in each species. Small RNAs in bacteria have been reported to be 
highly structured RNAs. We used the Mfold program to predict the secondary 
structure of the novel sRNA (Fig 18D), which shows the presence of a secondary 
loop and a hairpin structure at the 3‘ end representing the terminator of 
transcription. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 : A sRNA sequence with conserved regulatory elements is present in all Neisseria genomes 
available. And shows conservation in the 3‘ end of the gene. (A) Diagrammatic representation of the 
NMB1205 locus in MC58 strain of Neisseria meningitidis and other Neisserial spp. NMB1205 is 
annotated in MC58 only as a hypothetical ORF encoding a protein of 48 amminoacids. The 
organization of the locus in the other available genomes is indicated. The orientation and size of the 
annotated genes and the putative sRNA gene are indicated. There is similar organization in other all N. 
meningitidis, N. gonorrhoea N. lactamica, N. cinerea and N. polysaccharea genome sequences. The 
left flank of the locus appears to be a region of chromosomal rearrangment in the more distance spp.: 
N. flavescens and N. subflavia harbour a homologue of the NMB1727; N. mucosa a homologue of 
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NMB0875, N. strain F0314 (N. sp.) harbours a homologue of NMB1076 and N. sicca harbours a 
homologue of NMB1707, while in N. elongata an analogous sequence is present between a N. 
elongata-specific genes. (B) Alignment of the nucleotide sequence of the possible aniS analogous 
genes conserved in the available genome sequences of diverse N. spp. The regulatory sequences 
including an FNR-box and the possible -10 hexamer of a sigma 70 promoter, the +1 transcriptional 
start site as well as a rho-independent transcriptional terminator are conserved in all genomes and are 
highlighted in bold. The nucleotides conserved in 14 out 17 (80%) sequences are shaded in grey while 
the absolutely conserved in all sequences are indicated by the asterisk. The sRNA gene sequences 
vary at the 5‘ end of the putative RNA sequence cluster in groups and the relative identities exhibited 
between members of the indicated groups are shown. The alignment was made with the ClustalW 
software and further edited by hand 
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Figure 18: Characterization of the AniS transcript. (A) Northern Blot analysis showing a small 
transcript (<100nt) detectable in RNA from MC58 strain but not from the hfq strain. Total RNA 
was extracted from MC58 and hfq strains grown to log phase, Northern blotted and probed with a 
radiolabelled PCR product of 304 bp consisting of nucleotides overlapping the NMB1205 locus of 
the genome. The relative positions of migration of a RNA molecular weight ladder (run on the 6% 
PAGE 8M Urea gel) are indicated. (B) Mapping of the PaniS promoter. Total RNA (20 ug) from N. 
menigitidis MC58 strain was hybridized to the end labeled 1205-3 oligonucleotide (Table 5) and 
elongated with reverse transcriptase to map 5‘ end of transcription product synthesized by PaniS 
promoter. Precise mapping was performed by sequencing the cloned region in plasmid pGem-sR3 
with the same primer (lanes G, A, T, C). DNA regions corresponding to promoter elements are 
indicated in Figure 17. (C) In vitro transcripts synthesized with the T7 promoter from templates 
spanning (1) to the +106 end of the proposed transcriptional terminator and (2) to +155 downstream 
of the proposed transcriptional terminator. The relative lengths of the main transcript spp. 
synthesised are indicated. (D) Possible secondary structure of the novel AniS sRNA as predicted by 
MFOLD resulting in a free energy (G) of -20.8. The nucleotides conserved in other Neisseria spp. 
are indicated in bold and the regions of pairing with NMB1468 and NMB0214 target mRNAs are 
highlighted in black and grey respectively. 
 
 
1.17 The synthesis of the novel sRNA is regulated by FNR 
The FNR transcription factor regulates gene expression in response to oxygen 
deprivation in many bacteria by binding target sequences, called FNR-boxes 
located in promoters and usually activating but also repressing transcription. In 
order to investigate if the sRNA synthesis is under the control of the transcriptional 
regulator FNR we investigated transcript levels in cells of the wild type strain or a 
knock out mutant of FNR (fnr) incubated with or without oxygen. RNA was 
extracted from the wild strain and from the fnr mutant grown to mid log phase 
and then exposed or not to 30 minutes of oxygen limitation. Northern blot analysis 
revealed that, while the sRNA is weakly detectable in the wild type strain grown 
under aerobic conditions (Fig 19A, lane 1), levels are strongly induced in the wild 
type after exposure to oxygen limitation for 30 min (Fig 19A, lane 2). Furthermore, 
the absence of any signal in the fnr null mutant under either oxygen conditions (Fig 
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19A, lanes 3-4), indicates that the synthesis of the sRNA is positively regulated by 
FNR and that FNR activates its transcription in response to anaerobiosis or oxygen-
limitation. We therefore renamed the sRNA AniS (anaerobically induced sRNA). 
In order to investigate if the meningococcal FNR protein interacts directly with the 
aniS promoter region we carried out in vitro binding assay with a constitutively 
active mutant of meningococcal FNR protein, FNRD148A (Oriente et al., 2010), 
here named FNRC, which is no longer labile to oxygen. We prepared a probe of the 
promoter region of aniS radioactively labeled at one end only, and incubated it 
without or with increasing amounts of FNRC protein and subjected to DNase I 
footprinting, with the results shown in Fig 19B. A DNAse I protected region was 
observed on addition of the FNRC protein to the binding reaction which spans from 
position -30 to -50 with respect to the +1 transcription initiation site. The FNR 
binding site overlaps the FNR-box identified in the sequence at a correct distance 
for activation within the aniS promoter. This result demonstrates a direct role of 
FNR as a transcriptional activator of the synthesis of AniS. 
 65 
 
 
 
Figure 19 : Synthesis of AniS is induced under 
anaerobiosis through direct activation by the FNR 
transcriptional regulator. (A) Northern blot showing 
levels of AniS in total RNA from the wild type 
(MC58) and the FNR null mutant (fnr) which 
were exposed for 30 minutes to aerobic (+) or 
oxygen limitating (-) conditions. (B) FNR binds the 
PaniS promoter directly. DNase I footprinting 
analysis with purified meningococcal FNRc protein 
and a DNA probe of 322 bp, 5‘ radioactively end 
labeled at the NcoI site, corresponding to the PaniS promoter region. The probe was incubated with 
increasing concentrations of FNRc protein: lanes 1 to 3 correspond to amounts of 0, 0.12, 0.6 ug of purified 
protein. The arrows to the left show the position and direction of the aniS and NMB1206 genes. The FNR 
protected region is indicated to the right as a vertical black bar, and the numbers indicate the boundaries of 
the binding site with the respect to the +1 transcriptional initiation site 
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1.18 AniS negatively regulates NMB1468 and NMB0214 genes 
In order to find putative targets of the small RNA AniS, we reasoned that genes that 
are regulated by AniS should be substantially affected when the synthesis of the 
sRNA is maximal. Therefore, we generated a recombinant strain of MC58 
expressing the constitutively active form of FNR, MC_FNRC, in which the 
synthesis of AniS should be induced to a maximum level. We reasoned that genes 
that are regulated by AniS should be also regulated by FNR, therefore we 
determined the genes regulated in the FNRC expressing strain with respect to the 
wild type. In order to identify genes directly regulated by AniS we deleted the aniS 
gene in the MC_FNRC genetic background generating the strain aniS_FNRC and 
compared the global gene expression profile of these strains by microarray analysis. 
Total RNA from cultures of MC58, MC_FNRC and aniS_FNRC was prepared for 
microarray analysis and two independent experiments were performed: 1) 
MC_FNRC versus MC58 wild type and 2) aniS_FNRC versus MC_FNRC. By 
focusing on genes whose expression levels changed at least 2-fold reciprocally 
between the two experiments we thereby identified possible targets for AniS. Using 
these criteria, we found only five mRNAs that exhibited down regulation by FNR 
(MC_FNRC versus MC58 wild type) together with an upregulation when AniS was 
deleted in the same background (aniS_FNRC versus MC_FNRC) and only AniS 
itself exhibited the opposite regulation (Table 3). Four of these possible targets 
correspond to 2 loci of contiguous putative ORFs, NMB1468 and NMB1469 and 
NMB0119 and NMB0120, respectively which may represent bicistronic operons. 
NMB1468 encodes a putative conserved lipoprotein of unknown function and 
NMB1469 encodes a small hypothetical protein (which is not annotated in the other 
Neisserial genomes) while NMB0119 and NMB0120 are both hypothetical genes. 
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The fifth putative target for AniS is NMB0214, the oligopeptidase A encoding the 
prlC gene. RT-PCR analysis confirmed significant (over 2-fold) regulation in three 
of the five targets, NMB0214 and the NMB1468/NMB1469 operon (Table 3).  
The down-regulation of these target genes in the strain expressing FNRC and up-
regulation in response to deletion of the AniS sRNA suggests that AniS 
downregulates these target mRNAs when its synthesis is induced by FNR. To 
investigate further the role of AniS in regulating the NMB1468 and NMB214 genes 
we analysed expression of the targets in various recombinant strains with or without 
AniS, FNR and Hfq and correlated this with levels of AniS synthesis (Fig 20A-C). 
We extracted total proteins and RNA samples from 5 different strains and we 
measured AniS levels by quantitative primer extension, and mRNA target levels by 
RT-PCR to correlate the transcript amount of AniS with mRNA amounts of the 
targets. We also measured the expression of the NMB1468 protein, for which we 
had a polyclonal antiserum, to correlate transcript levels to protein expression 
levels. We found that under aerobic conditions AniS is synthesized at low levels in 
the wild type strain (Fig 20C, lane 1) and the abrogation of AniS synthesis by 
deletion of the FNR regulator, fnr, had little effect on the targets, either mRNA or 
NMB1468 protein expression (Fig 20A-C lane 2). However, when AniS synthesis 
is induced to high levels in the FNRC strain we observed a significant down 
regulation of the NMB1468 protein and the mRNA levels of both NMB0214 and 
NMB1468 targets (Fig 20A-C, lane 3). As seen with the microarray data, this 
downregulation is dependent on the AniS transcript and deletion of aniS in the 
FNRC background (aniS_FNRC) restores wild type levels of target expression 
(lane 4). Interestingly, if we remove the Hfq protein (hfq_FNRC, lane 5) in the 
FNRC background we no longer have downregulation of the targets and expression 
levels are similar to the wild type. This strongly suggests a role for Hfq in 
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mediating the AniS-dependent regulation. It is worth noting that high levels of 
AniS are synthesized in the hfq_FNRC strain but the targets are not downregulated 
suggesting that Hfq is essential in mediating the interaction with the target. Using 
bioinformatic tools (Fig 20D), we found putative pairings between AniS and the 
transcript of NMB1468 and NMB0214 which cover the region overlapping the 
ribosome binding site (RBS), a hallmark of negatively regulating sRNAs 
(Gottesman, 2004). These results suggest that the AniS transcript, together with the 
Hfq protein, mediates the downregulation of NMB1468 and NMB0214 target 
mRNAs and that the role of FNR in negative regulation of NMB1468 is mediated 
by AniS in a Hfq-dependent manner. 
To assay whether the specific accumulation of AniS in the same background had 
timely and therefore likely direct effects on NMB1468 and NMB0214 mRNA 
levels we performed a timecourse experiment of the induction of AniS synthesis by 
IPTG-induction of FNR
c
 expression and monitored the steady state levels of 
NMB1468 and NMB0214 mRNA over time. Figure 20E shows that AniS was 
overproduced after 5 mins of IPTG induction, and NMB1468 and NMB0214 
mRNA levels progressively decreased starting at 5 mins after induction. In the 
absense of the aniS gene no reduction in NMB1468 and NMB0214 mRNA was 
observed on IPTG-induction of FNR
c
. Therefore, AniS accumulation results in 
concomitant decreases of NMB1468 and NMB0214 mRNA steady state levels. 
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MC_FNR
C
 vs MC58

aniS_FNRC vs MC_FNRC 
Gene Microarray 
fold change 
RT-PCR fold 
change 
Microarray 
fold change 
RT-PCR fold 
change 
NMB1468 -3.5 -3.6 ± 0.7 +2.8 3.8 ± 0.7 
NMB1469 -3.5 ND +3.2 -ND 
NMB0214 -2.3 -2.2 ± 0.4 +2.5 +3.5 ± 0.4 
NMB1205 +4.6 ND -60 ND 
NMB0119 -4.6 -1.4 ± 0.8 +6.5 +2.8 ± 0.6 
NMB0120 -6.5 -1.6 ± 0.4 +9.8 +5.5 ± 0.8 
 
Table 3. Putative target genes of AniS. Genes differently regulated in MC_FNR
C 
 strain vs MC58 
and in aniS_FNRC  strain vs MC_FNRC. Microarray values represent a mean of three independent 
experiments each performed with a different pool of RNA as described in materials and methods. 
RT-PCR values represent a mean of two different experiments, each performed in triplicate, with 2 
biological replicas of RNA.  
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Figure 20 : FNR-induced downregulation of the NMB0214 and NMB1468 targets is mediated by 
AniS and dependent on Hfq. (A) Quantification by real time quantitative PCR of the NMB1468 and 
NMB0214 target transcripts in various genetic backgrounds. Total RNA was extracted from liquid 
cultures of following strains: the wild type MC58, the FNR null mutant fnr, the consitutively active 
FNR-expressing strain MC_FNRc , and its isogenic derivaties (grown in 1 mM IPTG for FNR 
expression) lacking the aniS gene aniS_FNRC, and Hfq  hfq_FNR C respectively. The steady 
state levels of the NMB0214 ad NMB1468 putative target transcripts were quantified by RT-PCR. 
The log fold changes were calculated with respect to the MC_FNRc strain and the values represent a 
mean of two different experiments, each performed in triplicate, with 2 biological replicas of RNA. 
(B) Western blot analysis was performed on total proteins from cultures of the strains indicated and 
stained with antisera raised against NMB1468 recombinant protein. NMB1869 protein expression 
was used as a negative control indicated by *. (C) Quantitative primer extension showing the levels 
of synthesis of AniS transcript in indicated strains. The level of adk housekeeping gene transcript 
was also quantified by primer extension using the adk-PE1 primer as a negative control in total RNA 
samples from each of the strains and is indicated by **. (D) The predicted target regions of 
complementarity between the AniS sRNA and its mRNA target genes. The numbers refer to the 
nucleotide positions with respect to the +1 of transcriptional initiation. 
(E) A timecourse experiment was performed on the MC_FNRc and aniS_FNRc strains grown to 
mid log in the absence of IPTG and then RNA was prepared before (0 min) or after addition of 1 
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mM IPTG at indicated timepoints. qRT-PCR was performed on each RNA preparation to assay 
NMB1468 and NMB0214 mRNA levels with 1468-F/1468-R and 0214-F/0214-R primers 
respectively and is plotted as a percentage of the level at T0. Quantitative primer extension was 
performed on the RNA preparations from the MC_FNRc strain using the 1205-3 primer to monitor 
AniS levels.  
 
1.19 Validation of the direct targeting of NMB1468 by AniS. 
To provide further evidence that AniS directly targets NMB1468, we used a GFP-
based plasmid system in the heterologus E. coli background that is routinely used to 
validate mRNA targets of heterologous sRNA (Urban & Vogel, 2007, Urban & 
Vogel, 2009). We cloned the 5‘ end of the NMB1468 gene including the upstream 
region into pXG-10 so that the first 10 amino acids were fused to GFP, and 
cotransformed this plasmid (or a control GFP fusion plasmid, pXG-1) with a 
compatible plasmid expressing the AniS gene from its own promoter (pGemT-
AniS) or the negative control without the AniS gene (pGEMT-). The overall level 
of GFP expression in the pXG-1 control plasmid was unaltered by the presence of 
the AniS gene (Figure 21A, lane 1 and 2). However, the expression of the 
NMB1468-GFP translational fusion when co-transformed with the pGEMT-AniS 
plasmid resulted in 3-fold less GFP than the strain with the pGEMT- plasmid (Fig 
21A, lane 4 vs 3) indicating that AniS down-regulated the NMB1468-GFP 
translational fusion in E. coli.  This data provides evidence that AniS targets the 5‘ 
end of the NMB1468 gene.  
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Figure 21 : AniS targets NMB1468 in E. coli and in vitro. (A) DH5- was co-transformed with either 
a control plasmid pXG-1 (GFP expressed from the Ptet promoter) or a NMB1468-GFP translation 
fusion (pXG-10-1468), and the compatible pGEMT-AniS aniS containing plasmid (+) or an 
equivalent plasmid without aniS (-), namely pGEMT-. Total protein from plate cultures of the four 
E.coli strains and the amount of GFP expressed in each was quantified byWestern blot. (B) AniS 
transcript forms an RNA/RNA duplex with the NMB1468 trancript via the complementary region 
proposed in Fig 20D. The radiolabeled AniS or mutant AniS (AniS_mut) in vitro transcripts (0.5 
pmol/reaction or 50 nM final concentration) were incubated with increasing concentrations of cold 
NMB1468 (1468) or mutant NMB1468 (1468_mut) in vitro transcripts (lanes 1 to 5: 0, 0.5, 1, 2, 4 
pmols or 0, 25, 50, 100 and 200 nM) in the presence of 1 ug tRNA from E. coli as a nonspecific 
competitor. The presence of a slower-migrating RNA/RNA duplex is formed on co-incubation of wild 
type AniS and NMB1468 transcripts or the AniS_mut and 1468_mut transcripts containing 
compensatory mutations only.  
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The interaction of AniS with the NMB1468 mRNA was assayed by gel-shift 
analysis. Radioactively labelled AniS was incubated with in vitro generated mRNA 
corresponding to the first 217 nucleotides of the NMB1468 mRNA and containing 
the predicted region of base-pairing (Fig 20D) to assay duplex formation. Addition 
of increasing amounts of NMB1468 transcript resulted in a shift of the AniS probe, 
confirming that these RNAs can interact (Fig 21B, panel I). To validate the 
proposed region of interaction, site directed mutagenesis was performed on the 
AniS transcript (Fig 20D), and the mutant transcript (AniS_mut) did not interact 
with the wild type 1468 transcript (Fig 21B, panel II) however, the interaction was 
restored by the introduction of compensatory mutations to the 1468 transcript 
(1468_mut) (Fig 21B, panel III). These experiments confirm that AniS interacts 
with NMB1468 mRNA through base-pairing of the proposed region. 
 
1.20 AniS is a small RNA bound by Hfq 
In order to determine if Hfq can interact with the AniS transcript we performed in 
vitro gel mobility shift experiments with in vitro-synthesized AniS and the 
meningococcal Hfq recombinant protein. Radioactively labeled AniS transcript was 
incubated with increasing amounts of purified Hfq protein in the presence of 100 
fold excess of tRNA as nonspecific competitor (Fig 22A). The addition of 11 nM 
Hfq resulted in the complete retardation of the radioactively labeled AniS with the 
formation of the first stable complex CI (lane 2) and on addition of 100 nM Hfq a 
second slower migrating complex was formed (CII, lane 4). This suggests that 
either one or two oligomers of Hfq can bind AniS. It is worth mentioning that Hfq 
shows affinity for the AniS transcript similar to that of previously reported Hfq-
dependent sRNAs (Moller et al., 2002; Metruccio et al., 2009; Papenfort et al., 
2006). Most E. coli sRNAs are less stable in the absence of Hfq (Moll et al., 2003; 
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Moller et al., 2002; Sledjeski et al., 2001), presumably because Hfq protects 
sRNAs from degradation in the absence of base pairing with mRNAs. Since AniS 
levels are less in the Hfq mutant we decided to measure the stability of AniS in the 
presence or absence of the Hfq protein in vivo. We used the FNRc-expressing 
strain, as AniS synthesis was maximal in this background, and performed a 
rifampicin timecourse extracting RNA from the MC-FNRc (Hfq+) or hfq_FNRc 
(Hfq-) strains at indicated timepoints after rifampicin addition and measured the 
decay of the AniS transcript (Fig 22B and C). Unexpectedly, the experiment 
revealed that the AniS transcript was rapidly degraded in the Hfq+ background 
(half life <2 min), whereas the RNA was more stable in the Hfq- background (half 
life > 10 min) indicating that, Hfq has a negative effect on the stability of AniS. 
Taken together with previous data, our results suggest that Hfq may be important as 
a cofactor which facilitates the interaction between AniS and its target mRNAs, and 
we suggest that this could lead to a more rapid turnover of the sRNA. 
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Figure 22: Binding of Hfq to the in vitro transcribed AniS sRNA transcript.  
(A) Electrophoretic mobility shift assay of radioactively 5‘-end labeled AniS transcript (0,5 
pmoles/reaction or 50 nM final concentration) with increasing concentrations of the purified Hfq 
protein [lanes 1 to 4: 0, 11, 33, 100, 300 nM] was performed in the presence (+) or absence (-) 
(panel I and II) of 31 mM of tRNA per reaction. Specificity of the binding was assayed by co-
incubation of AniS and 16 nM Hfq with increasing amounts of indicated tRNA (non-specific 
competitor, panel III) and cold AniS (specific competitor, panel IV). The free RNA probe (AniS) 
and the slower-migrating RNA/protein complexes (CI–CIII) are indicated. 
 (B) Quantification of decay of AniS transcript in Hfq+ and Hfq- backgrounds. The MC_FNRc 
(hfq+) and the hfq_FNRc (hfq-) strains were grown to log phase and, at indicated timepoints, after 
the addition of 80 ug/ml of rifampicin the cells were added to an equal volume of frozen media to 
bring immediately to 4°C and RNA was extracted. Primer extension with the 1205-3 end-labelled 
primer was performed on 15 ug of total RNA from each sample from each timepoint to measure 
AniS levels. (C) Levels of AniS were quantified in each sample using a phosphoimager and the 
relative amounts of AniS were plotted and used to estimate the half-life in each background.  
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III Molecular mechanism of action of the sRNA NrrF 
 
1.21 A bionformatic approach identified a Fur-regulated sRNA in 
the N. meningitidis MC58 genome  
In N. meningitidis the majority of iron-responsive gene
 
regulation is mediated by 
the ferric uptake regulator protein
 
(Fur), a protein classically defined as a 
transcriptional repressor (see introduction). Recently, however, microarray 
experiments with the Fur null mutant indicated that Fur positively regulates 43 
genes in N. meningitidis (Delany et al., 2006), and a subset of these showed no 
evidence for direct binding of Fur in their promoter regions. Interestingly, Fur has 
been shown to indirectly activate gene transcription
 
through the repression of small 
regulatory RNA molecules in
 
other organisms (Wilderman et al., 2004; Masse & 
Gottesman, 2002; Davis et al., 2005), so we looked for a similar mechanism in 
menignococcus. We used a bionformatic approach to screen for the presence of a 
Fur-regulated sRNA. We generated a weight matrix by aligning sequences from 24 
Fur-binding sites identified by footprint analyses (Delany et al, 2006) to screen 
both strands of the N. meningitidis genome sequence. All binding sites mapping 
upstream of genes that are known to be regulated by Fur and iron, were analysed 
further for both the proximal presence of a likely rho-independent transcriptional 
terminator (within 250 bp), and also for conservation across the available neisserial 
genomes, meningococcus, gonnorhoeae and lactamica. This analysis lead us to the 
identification of a single top candidate for a Fur-regulated sRNA and the locus is 
schematically represented in Figure 23 and it was called NrrF (neisserial regulatory 
RNA responsive to iron [Fe]). The nrrF gene maps between two predicted 
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converging genes, NMB2073 and NMB2074 (Fig 23). A putative Furbox sequence 
overlaps an A/T rich region with strong similarity to sigma 70 promoter sequences, 
namely a –10 hexamer (TATAAT) and a –35 (TTGATA), suggesting that this 
region may contain a Fur-regulated promoter, and flanked at a distance of 156 bp 
with a predicted rho- independent terminator. 
 
 
 
 
 
 
Figure 23: Diagrammatic representation of the locus containing the nrrF gene in MC58. The 
sequence with the regulatory elements verified in this study are indicated .The Fur-box is indicated 
as a grey rectangle, the transcriptional start of the gene is highlighted with a broken arrow, the rho-
independent transcriptional terminator is indicated with a hairpin loop, and the orientation of the 
sRNA gene is indicated with a black arrow. 
 
 
1.22 A base pairing mechanism mediated by Hfq is the molecular 
mechanism of action of NrrF  
It was demonstrated (Mellin et al., 2007; Metruccio et al., 2009) that NrrF is a 156 
nt sRNA whose transcription is negatively regulated by Fur. Furthermore by 
microarray analysis it was found that NrrF down-regulates the succinate 
dehydrogenase operon (Metruccio et al, 2009). In order to understand the molecular 
mechanism of action of NrrF to regulate the sdh operon, we considered that in 
general small regulatory RNAs act by base-pairing to complementary
 
regions in 
their mRNA targets. By using the computer program
 
BESTFIT of the GCG 
Wisconsin package, we analyzed the nucleotide
 
sequence corresponding to the sdh 
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transcript from the 5' untranslated
 
end to beyond the sdhB 3' end for the most likely 
region of
 
interaction between this RNA molecule and the sRNA. An extended
 
region of imperfect base-pairing is shown in Fig. 24A, which
 
overlaps the 3' end of 
the sdhD gene and the 5' end of the sdhA
 
gene. As predicted by the Mfold computer 
program, the NrrF RNA may fold
 
in a secondary structure (Fig. 24B). The proposed 
interacting
 
region of the sRNA molecule is largely present in the single-stranded
 
loop 28-58, which would be available for base-pairing for the
 
overlapping region of 
the start of translation of the sdhA gene.
 
Interestingly, the predicted structure of the 
sRNA molecule
 
shows a putative Hfq-binding site, which is an 8- to 12-nt AU-rich
 
region adjacent to stem-loops (Moll et al., 2003), suggesting that the Hfq
 
protein 
may be involved in binding and mediating NrrF function, as already observed for 
AniS (see above).
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Figure 24: (A) Diagrammatic representation of the sdhCDAB locus and the extended region of 
complementarity found between the NrrF and the sdhDA mRNA gene junction. (B) The predicted 
structure (Mfold) of the NrrF sRNA resulting in a free energy of (Gº) –42.2. The predicted AU-
rich Hfq binding site between 94 and 104 nt in the sequence is boxed, and the nucleotides involved 
in the putative base-pairing with sdhDA mRNA are shown in bold. The arrows indicate the positions 
of the first and last nucleotides of the18 deletion of the loop that was generated for the Nrrf31-58 
mutant transcript (Fig 25B). 
 
 
In order to determine whether Hfq interacts with NrrF, we performed
 
in vitro gel 
mobility shift experiments with in vitro-synthesized
 
NrrF and the meningococcal 
Hfq recombinant protein. The NrrF
 
in vitro transcript was radioactively end labeled 
and incubated
 
with increasing amounts of purified Hfq protein, and protein-RNA
 
complex formation was monitored as slower-migrating bands in
 
native 
A 
B 
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polyacrylamide gels. Figure 25A shows the results of gel
 
shift experiments with the 
NrrF transcript and increasing amounts
 
of Hfq in the absence (I) or presence (II) of 
a >100-fold
 
excess of tRNA as a nonspecific competitor. In the presence
 
of 
nonspecific competitor, the addition of 2.4 nM Hfq resulted
 
in retardation of the 
radioactively labeled NrrF probe and the
 
formation of the first stable complex, CI 
(Fig. 25A, panel II,
 
lane 3), and on addition 60 nM Hfq a second slower-migrating
 
complex was formed (CII) (lane 5). This suggests that either
 
one or two oligomers 
of Hfq can bind to NrrF. Hfq shows high
 
affinity for the NrrF transcript with an 
apparent Kd of 36 nM. Furthermore, we assessed possible duplex formation of 
NrrF with
 
two different possible target RNAs. We synthesized in vitro
 
the predicted 
sdhDA target transcript region and also the 5'UTR
 
of the sdh transcript, initiating at 
the promoter upstream of
 
sdhC, as a likely alternative. We then incubated the 
radioactively
 
labeled NrrF with increasing amounts of either of the putative
 
target 
transcripts and assayed duplex formation by gel shift
 
assays. As shown in Fig. 25B 
(panels I and II), while the addition
 
of the unlabeled sdhDA region resulted in the 
retardation of
 
the NrrF probe and the formation of a weakly resolved slower-
migrating
 
band, the 5'UTR-sdhC probe had no significant effect on the
 
mobility of 
NrrF, suggesting that indeed the sdhDA predicted
 
region can act as a target for 
RNA-RNA duplex formation in vitro.
 
Furthermore, we generated a mutant NrrF 
transcript with a deletion
 
from positions +31 to +58 lacking most of the single-
stranded
 
loop containing the proposed sdhDA interacting region of the
 
sRNA 
molecule (Fig. 24B). This in vitro transcript is predicted
 
to maintain a similar 
secondary structure with a just a smaller
 
loop; however, addition of unlabeled 
sdhDA did not result in
 
retardation of the shorter probe (Fig. 25B, panel III), 
suggesting
 
that the loop is indeed important for base-pairing and duplex
 
formation.
 
Finally, we performed binding reactions of NrrF and the sdhDA
 
target region with 
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or without the coincubation of the Hfq protein.
 
Figure 25C shows the results of gel 
shift analysis in which on
 
coincubation of Hfq with NrrF and sdhDA a supershifted 
band
 
was observed (lanes 6 to 8) with slower migration than the Hfq-NrrF
 
protein 
complexes (lane 2) or the sdhDA-NrrF duplex (lane 5),
 
which likely represents the 
migration of a ternary complex formed
 
by Hfq, NrrF, and the sdhDA target. 
Furthermore, the addition
 
of Hfq to the binding reactions considerably enhances the 
efficiency
 
of NrrF-sdhDA interaction since the ternary complex is clearly
 
visible 
even at 22 nM sdhDA (lane 6), whereas the duplex is
 
clearly visible only at 90 nM 
sdhDA (lane 5). These experiments
 
suggest that Hfq interacts with NrrF and 
promotes the direct
 
base-pairing at the predicted complementary sdhDA region of
 
the sdhCDAB mRNA. We propose that these interactions in vivo
 
may result in an 
Hfq-dependent decay of the sdhCDAB mRNA by
 
direct targeting by the Fur-
regulated sRNA NrrF. 
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Figure 25: (A) In vitro binding of the Hfq protein to the NrrF transcript. Electrophoretic mobility 
shift assays of radio-actively 5‘ end-labeled NrrF transcript (0.5 pmoles/reaction or 50 nM final 
concentration with increasing concentrations of the purified Hfq protein (lanes 1-6: 0, 0.5, 2.4, 12, 
60, 300 nM) in (I) the absence (-) or (II) the presence (+) of 10 μg of tRNA per reaction (i.e. a final 
concentration of 31 μM). The free RNA probe (NrrF) and the slower migrating RNA/protein 
complexes (CI-CII) are indicated to the right of each panel. (B) The NrrF transcript forms an 
RNA/RNA duplex with the putative complementary region within the sdhDA mRNA but not the 
5‘UTR of sdhC in vitro. The radio-labeled NrrF probe or mutant probe Nrrf31-58 (with a deletion 
from +31 to +58 inclusive) (0.5 pmoles/reaction or 50 nM final concentration) was incubated with 
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increasing concentrations of cold sdhDA (I and III) and sdhC (II) in vitro transcripts (lanes 1-5: 0, 
0.22, 0.45, 0.9,1.8 pmoles, or 0, 22, 45, 90, and 180 nM final concentration) in the presence of 31 
μM tRNA from E. coli as non-specific competitor. The presence of a slower migrating RNA/RNA 
duplex is formed on addition of the sdhDA but not the 5‘ sdhC cold probe to the wild type Nrrf 
probe. (C) Co-incubation of NrrF with Hfq increases the efficiency of target sdhDA binding and a 
higher migrating ternary complex is observed. The radio-labeled NrrF probe (0.5 pmoles/reaction or 
50 nM final concentration) was incubated with increasing concentrations of cold sdhDA transcript  
(lanes 3-5 and 6-7: 0.22, 0.45, 0.9, 2 pmoles or 22, 45, 90 nM final concentration, respectively) in 
the absence (lanes 1, 3-5) or presence (lanes 2, 6-8) of 12 nM of purified Hfq protein. 
 
1.23 Fumarate hydratase and superoxide dismutase are regulated 
by at least a novel Hfq-dependent sRNA  
In vitro experiments showed that Hfq has a role in stabilizing the base pairing 
between NrrF and sdhA mRNA target (Fig 25) and microarray analysis showed that 
NrrF has a role in down-regulating the RNA steady state level of sdh (Metruccio et 
al, 2009). In order to investigate the effects of NrrF and Hfq also on the SdhA 
expression we performed
 
Western blot analysis with antiserum raised in mice to the 
SdhA
 
protein to investigate the levels of protein expression in the
 
MC58 strain and 
derivatives lacking Fur, NrrF, or the Hfq protein.
 
As shown in Fig. 26A, SdhA 
protein is highly expressed in the
 
MC58 strain and the Fur-complemented 
derivative and is downregulated
 
in the Fur mutant, as expected. The deletion of the 
nrrF gene
 
or the hfq gene in the MC58 wild type background both result
 
in a slight 
induction of SdhA levels (lanes 2 and 6, respectively)
 
with respect to the wild type 
levels. Furthermore, the deletion
 
of the nrrF gene or the hfq gene in the Fur 
knockout background
 
results in a high level of expression of the SdhA gene even
 
in 
the absence of the Fur protein (lanes 4 and 7), suggesting
 
that both NrrF and Hfq 
are involved in downregulation of SdhA
 
expression in meningococci. Moreover, the 
down-regulation of
 
SdhA in the Fur mutant may be mediated by NrrF and Hfq.  
Interestingly analyzing other genes that from previous microarray studies (Delany 
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et al, 2006) resulted to be Fur positvely regulated we found, by Western blot 
analysis, that FumB (fumarate hydratase) expression in the same strains shows an 
expected Fur-dependent positive
 
regulation, in that the levels of protein were 
undetectable
 
in the Fur-null mutant and restored to detectable levels in
 
the 
complemented strain, as expected (lanes 1, 3, and 5). But, although
 
the 
downregulation of FumB in the Fur mutant was not altered
 
by the deletion of the 
nrrF gene (lane 4 versus lane 3), the
 
deletion of the Hfq protein either in the wild 
type or the Fur
 
mutant background significantly upregulated FumB expression
 
(lanes 6 and 7). These data suggest that Fur-mediated positive
 
regulation of fumB 
may be mediated by an Hfq-dependent mechanism,
 
but not by the NrrF sRNA, 
suggesting another Hfq-dependent sRNA
 
is involved. We also investigated the role 
of Hfq on the positive iron and Fur regulation of
 
the sodB gene by assessing the 
steady-state
 
levels of sodB transcript in the single and double Hfq and Fur
 
mutants. 
The results of quantitative primer extension in Fig.
 
26B show that the sodB 
transcript is downregulated under iron-limiting
 
conditions in the wild type MC58 
(lane 2 versus lane 1) but
 
remains constitutively high in the hfq mutant (lane 4 
versus
 
lane 3). Furthermore, the downregulation of sodB in the Fur
 
mutant (lanes 5 
and 6 versus lane 1) is reverted to constitutive
 
high expression in the Fur-hfq 
mutant on deletion of hfq (lanes
 
7 and 8). These results suggest that Hfq mediates 
Fur and iron-regulation
 
of sodB and strongly suggests that another Hfq-dependent 
sRNA
 
is involved in Fur-mediated positive regulation of sodB in meningococcus.
 
In 
conclusion, our data suggest that Fur regulation of sdhCDAB
 
is mediated by NrrF in 
an Hfq-dependent manner and that the
 
regulation of sodB and fumB is due to the 
Hfq-dependent action,
 
possibly via a second Fur-regulated sRNA that is distinct 
from
 
NrrF. 
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Figure 26: (A)Expression of SdhA and FumB proteins, both regulated positively by Fur, in strains 
deriving from the MC58 wild type, with or without the fur gene, the nrrF gene and/or the hfq gene. 
Western Blot analysis was preformed on total proteins from overnight plate of the strains indicated 
and stained with antisera raised against the SdhA and FumB proteins. The expression of the Fur 
protein (17kDA) and the Hfq protein (11kDa) were verified in the appropriate strains lower panel. 
NMB1870 protein expression was used as a negative control as it is neither Fur nor iron-1 regulated 
(Delany et al, 2003). (B) RNA analysis by quantitative primer extension of the levels of the sodB 
transcript in wild type (MC58), Hfq null mutant (hfq), the Fur mutant (MC-Fko), and the double 
Fur-Hfq mutant (Fko-Hfq) grown to mid-log phase under iron replete conditions before (+) and after 
(-) treatment for 15 min with iron chelator. 
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IV. Global investigation of sRNAs 
 
1.24 Solexa RNA sequence revealed 19 putative novel sRNAs in 
menigococcus  
The Fur and Hfq dependent regulation of fumB and sodB genes suggests that other 
iron-regulated sRNAs are involved in the Fur-mediated positive regulation of these 
two genes. In order to deeply and globally investigate iron-dependent sRNAs 
network in N. meningitidis we applied Illumina‘s high throughput sequence 
technology to analyze the transcriptome of this bacterium. RNA was prepared from 
3 independent cultures of N. meningitidis MC58 grown to mid log phase in GC 
broth and then subjected or not to iron chelation (as described in Materials and 
Methods). The RNA was reverse transcribed to cDNA and sequenced on an 
Illumina GAI. The resulting 36-base reads were mapped to the N. meningitidis 
MC58 genome. The sequence coverage per base was subsequently plotted and 
visualised using the genome browser Artemis (Rutherford et al., 2000). It was 
reported (Perkins et al, 2009) that this method yields RNA transcript reads in a 
strand-specific manner allowing the identification of antisense transcripts. 
However, as we observed the same signal both from the antisense and the sense 
strand in our data set, we did not succed in obtaining strand-specific signal. In order 
to facilitate the analysis we summed the signals obtained from the sense and the 
antisense strand. To find novel sRNA candidates we searched for cDNA peaks that 
occurred specifically and entirely within intergenic regions in at least 2 of the 3 
biological replicates, excluding ribosomal RNAs. For each candidate we calculated 
the arithmetic mean per base-pair (nt/bp) of mapped sequence reads and we 
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considered only regions in which nt/bp was ≥ 1 in an least 2 of the 3 biological 
replicates. In order to discriminate from 5‘ or 3‘ UTRs the distance from the 
upstream and the downstream genes was also calculated and only regions which a 
distance > 30 nt  were considered. Following these steps we were able to identify 
23 putative non coding small RNAs (NCRs), 16 of which resulted to be up-
regulated under iron limitation, which are listed in Table 4 and some of them 
represented in Fig 27. Since sRNAs are in general conserved in phylogenetically 
related species the sequence conservation in other Neisseria gonnorhoeae and 
lactamica species was also evaluated (Table 4). 3 of the 23 candidates were derived 
from tRNA (NCR-) and housekeeping RNAs (NCR-, tmRNA and NCR-, 6S). 
Interestingly NCR-4 is the previously described sRNA NrrF  which demonstrates 
proof of concept for this analysis (Table 4). This result confirms the efficency of 
the Solexa method in identifying non coding small RNAs. Taking together these 
results strongly suggest the existence of novel sRNAs, some of which could be 
involved in the post-transcriptional regulation of sodB and fumB genes (fig 26). 
Further studies are needed in order to validate the existence of the putative 19 
sRNAs and, once confirmed, to characterize their regulatory networks.  
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Figure 27: Previously known non-coding RNAs, as listed in Table 4. 
RNA-seq data sequence were mapped to the N. meningitidis  MC58 genome and visualized using 
Artemis software. Blue and red arrows represent the coding genes and non coding RNAs 
respectively. The nucleotide coverage (nt/bp) is indicated on the left and represents the mean of the 
three biological replicates. Numbers on the left are in accordance with Table 4.    
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Table 4.  putative small RNAs identifed by RNA-seq 
 
NCR-ID Upstream
A
 Downstream
B
 Orientation
C
 nt/bp 
RNA 
length Conservation
E
 
nt from 
upstream 
nt from 
downstream 
Regulation 
in dip. 
1 NMB1015 NMB1016 >< 4.3 338 Yes 604 666 Yes 
2 NMB1587 NMB1588 << 3.7 93 Yes 180 523 No 
3 NMB2057 NMB2058 << 3.1 54 Yes 248 61 No 
4 NMB2073 NMB2074 >< 7 58 Yes 61 965 Yes 
5 NMB0553 NMB0554 << 2.8 54 No 729 425 Yes 
6 NMB0983 NMB0984 >> 2.3 82 Yes 224 307 Yes 
7 NMB0992 NMB0993 << 2.5 52 No 1254 626 Yes 
8 NMB0993 NMB0994 << 3.1 322 Yes 322 39 Yes 
9 NMB1391 NMB1391 << 10.4 95 Yes 151 34 No 
10 NMB1451 NMB1452 <> 7.8 55 Yes 459 302 Yes 
11 NMB1451 NMB1452 <> 6.6 62 Yes 574 180 Yes 
12 NMB1865 NMB1866 << 4 54 Yes 177 32 Yes 
13 NMB1865 NMB1866 << 3.8 54 Yes 338 162 Yes 
14 NMB1921 NMB1922 >< 2.4 101 Yes 93 78 Yes 
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15 NMB1923 NMB1924 >< 5.9 55 Yes 86 77 Yes 
16 NMB1982 NMB1983 >> 3.8 85 Yes 87 1174 Yes 
17 NMB1982 NMB1983 >> 3.7 71 Yes 187 1088 No 
18 NMB0395 NMB0396 >> 4.6 56 No 40 122 No 
19 NMB1488 NMB1489 <> 2.2 54 Yes 82 351 No 
20 NMB1636 NMB1637 >< 11 110 Yes 45 46 No 
21 NMB0047 NMB0048 >< 2 16 Yes 1263 1296 Yes 
22 NMB0195 NMB0196 >< 3.2 54 No 176 1068 Yes 
23 NMB0400 NMB0401 >< 3 54 Yes 552 428 Yes 
 
 
The respective upstream (A) and downstream (B) genes are indicated as well as their orientation (C) in the genome. The conservation in other Neisserial 
species was also evaluated (E). Number 1-4 represent already known sRNAs (Fig. 27) 
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DISCUSSION 
It is very well established that sRNAs play critical regulatory roles in many bacteria 
in response to different stress conditions, and in many pathogens they have been 
found to have important roles in virulence and host infection (for review see Zhou 
& Xie, 2011; Papenfort & Vogel, 2010; Toledo-Arana et al., 2007; Gripenland et 
al., 2010) .Although they have such important roles in bacteria many of them have 
been identified only very recently. This resides in part due to the difficulty in 
identifying novel sRNAs, since, unlike regulatory proteins, they are not annotated 
in bacterial genome sequences and their sequence is not conserved between 
different bacterial species. Nowadays, thanks to the increased availability of novel 
technologies such as computational predictions of sRNAs, tiling arrays and high-
throughput cDNA sequencing (RNA-seq) many novel sRNAs have been discovered 
in a wide range of bacteria, but in many systems, including Neisseria spp., their 
existence is still largely unexplored. In this thesis we have initiated the 
characterization of the sRNA network of N. meningitidis, demonstrating that a hfq 
knock out mutant displays a pleiotropic phenotype and identifying two novel 
sRNAs using bioinformatic and microarray-based approaches. Furthemore, using 
Solexa technology, to sequence the transcriptome of meningococcus, we discovered 
19 putative novel sRNAs which will be further investigated. 
 
1.25 Characterization of a hfq knock out mutant in Neisseria 
meningitidis  
In this section we investigated the role of Hfq in the stress
 
tolerance and virulence 
of meningococcus. We report that Hfq
 
has a profound effect on the fitness and 
survival of meningococcus
 
in the presence of a wide range of stresses (Fig 13) and 
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contributes
 
to virulence in ex vivo and in vivo models of infection (Fig 14). The 
stress sensitivity of the hfq mutant is consistent with
 
the altered stress responses 
observed for other bacteria (Christiansen et al., 2004; Robertson & Roop, 1999; 
Tsui et al, 1994; Meibom et al, 2009; Geng et al., 2009; Sousa et al., 2010) 
suggesting that Hfq has a conserved function in meningococcus.
 
The ability of 
meningococci to colonize the hostile environment
 
of the mucosal epithelium and 
their ability to survive and multiply
 
within human blood are key factors in the 
development of fulminant
 
meningococcal disease. In the current models of 
bacteremia,
 
the mutant is considerably attenuated (Fig 14C). The ability
 
of this 
strain to survive in human blood and serum is not attributed
 
to altered expression of 
known serum resistance factors of N.
 
meningitidis, such as a capsule (Jarvis & 
Vedros, 1987) or fHbp (Madico et al., 2006), as these
 
factors were not altered by 
the mutation (data not shown). Hfq
 
was important for survival in the infant rat 
animal model
 
over an 18-h period. Although we cannot exclude the possibility
 
that 
the growth phenotype of this strain may partially explain
 
the reduced number of 
bacteria recovered from the blood, this
 
was certainly not the case in the ex vivo 
assays, where in media
 
or heat-inactivated serum the three strains showed no 
decreases
 
in cell numbers over the course of the assay (data not shown).
 
Interestingly, in agreement with our findings, signature-tagged
 
mutagenesis 
screening for attenuated mutants of meningococcus
 
resulted in isolation of an Hfq 
mutant as 1 of 73 mutants that
 
were attenuated in the infant rat (Sun et al., 2000). 
Here we performed a proteomic and a whole genome expression analysis of cells 
lacking Hfq
 
to identify proteins and processes that are directly or indirectly
 
regulated by this protein, thus providing potential target genes
 
for sRNA regulation. 
Analysing the proteins or genes differently regulated in hfq, we found 27 proteins, 
of which 20 were overproduced in the Hfq mutant, and 152 genes, 112 up regulated 
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and 40 down regulated in hfq. These results suggest that Hfq acts more often to 
repress rather than to activate gene expression in N. meningitidis. Many of these 
genes are involved in
 
cell energetics and metabolism, amino acid biosynthesis, 
oxidative
 
stress responses, and pathogenesis (Tables 1 and 6). Considering the 
pleiotropic
 
effect of Hfq on mRNA stability and translational regulation
 
in other 
bacteria, it is likely that many of the Hfq-dependent
 
changes in protein expression 
or mRNA regulation are mediated by altered sRNA circuits. Interstingly we can 
notice that four genes that we found to be differently regulated in the Hfq knock out 
were reported to be under
 
probably direct control of sRNAs in other systems, 
namely prpC,
 
gltA, acnB, and sodB (Oglesby et al., 2008; Masse & Gottesman, 
2002). Interestingly,
 
we identified a number of OMPs whose accumulation was 
altered
 
in the hfq mutant, although the major expressed OMPs PorA, PorB, and 
RmpB did not appear to be affected. While regulation
 
could be indirect, the fact that 
many OMPs are upregulated in
 
the hfq mutant raises the possibility that OMP 
biogenesis and
 
outer membrane composition may be extensively regulated by 
sRNAs
 
in meningococcus, as has been reported for other systems (Valentin-Hansen 
et al., 2007; Vogel & Papenfort, 2006). 
The phenotypes associated with loss of Hfq in meningococcus
 
may not be 
completely dependent on its role in directing sRNA
 
posttranscriptional circuits but 
instead may be related to other
 
Hfq functions or some additional factor or factors 
that are
 
themselves targets for Hfq regulation. For instance, in E. coli
 
Hfq is known 
to interact with the polynucleotide phosphorylase
 
(PNPase) and poly(A) polymerase 
I (PAPI) proteins, two components
 
of the degradasome, in an sRNA-independent 
manner (Mohanty et al., 2004). Here,
 
PNP is identified as one of the proteins that is 
less abundant
 
in the hfq mutant, and it is plausible that the turnover of the protein 
itself is altered in the absence of Hfq. Alternatively,
 
the binding of an RNA-binding 
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protein, such as Hfq, directly
 
to mRNA might favor alternative mRNA secondary 
structures that
 
may either promote or interfere with translational initiation
 
or that 
may alter the rate of mRNA degradation, as is the case
 
for Hfq-mediated 
downregulation of OmpA in E. coli (Vytvytska et al., 2000). Many
 
of the pleiotropic 
effects of Hfq mutants in other bacterial
 
systems are related to the requirement of 
Hfq for efficient
 
translation of the stationary-phase sigma factor (Brown & Elliott, 
1996); Tsui et al, 1994) or
 
for downregulation of RpoE and the envelope stress 
response (Ding et al., 2004; Figueroa-Bossi et al., 2006; Guisbert et al., 2007; 
Thompson et al., 2007). While N. meningitidis does not possess an
 
RpoS-like sigma 
factor, a protein annotated as an extracellular
 
function sigma factor (NMB2144) 
with similarity to RpoE is present.
 
However, there are no homologues of the 
periplasmic protease
 
DegS or the anti-sigma factor RseA, which are responsible for
 
activation of RpoE in response to envelope stress.
 
 
A comparison of the initial observations for Hfq phenotypes
 
for meningococcus and 
other better-studied systems shows many
 
similarities but also some interesting 
differences. It appears
 
that Hfq plays a pivotal role in virulence and stress 
adaptation.
 
In the absence of a stationary-phase sigma factor and homologues
 
of the 
proteins which activate the envelope stress response,
 
the mechanisms by which Hfq 
could contribute to control global
 
protein expression regulation may differ from the 
mechanisms
 
in other systems. Nonetheless, due to the pleiotropic nature
 
of the 
phenotypes of the Hfq mutant, it appears that Hfq plays
 
a fundamental role in 
coordinating gene regulation in meningococcus,
 
and our findings indicate that there 
is a large sRNA network
 
in N. meningitidis that has yet to be uncovered.  
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1.26 Identification of AniS: a novel sRNA synthesied under oxygen 
limitation 
The global analysis of transcripts affected in the Hfq knockout, allowed us to 
identify a small transcript that we show to be a novel regulatory sRNA of 
meningococcus, which we called AniS. AniS is a Hfq-dependent sRNA of about 
100 nucleotides, and in this thesis we describe the signals and regulatory circuits 
which decide its synthesis as well as candidate target mRNAs that it regulates. AniS 
is an anaerobically-induced sRNA whose synthesis is strictly dependent on the 
FNR global anaerobic transcriptional regulator and thus, it can hardly be detected in 
cells deleted for the fnr gene or in cells grown aerobically. FNR binds the aniS 
promoter directly and activates transcription of the sRNA in response to oxygen 
limitation.  
Through transcriptome profiling in appropriate mutants we identified at least 2 
possible targets of AniS, NMB1468 and NMB0214. The downregulation of the 
mRNAs of these genes is mediated by the AniS gene and also by Hfq. The 
expression of constitutively active FNR, FNRc, induces high levels of AniS and 
concomitant downregulation of these target mRNAs, and AniS and Hfq are 
necessary for this downregulation. We also showed a direct interaction of Hfq to 
the AniS sRNA suggesting that Hfq may be directly involved in mediating sRNA 
base-pairing to its target mRNAs. Both NMB1205 (aniS) and NMB1468 were 
reported to be FNR-regulated in Neisseria in independent microarray studies of the 
FNR deletion mutant and the wild type exposed to oxygen limiting conditions 
(Bartolini et al., 2006; Whitehead et al., 2007). 
The identified regions of complementarity of AniS for NMB1468 and NMB0214 
were overlapping the RBS and flanking regions, typical of this class of regulators. 
Interestingly the same region of AniS is predicted to pair with each target and 
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contains a pyrimidine-rich region spanning from nt 51 to 62 CUCUUUCCUCU 
somewhat resembling an anti-Shine-Dalgarno (aSD) sequence. The NMB0214 and 
NMB1468 gene targets of AniS, respectively encode the PrlC oligopeptidase whose 
exact function is still unknown although it has been implicated in protein export, 
degradation and cell cycle regulation in E. coli (Trun & Silhavy, 1989, Jain & 
Chan, 2007; Jiang et al., 1998), and a lipoprotein of unknown function which has 
been studied as a possible candidate antigen for a meningococcal vaccine (Hsu et 
al., 2008). Therefore, it is difficult to envisage a logical rationale for their 
downregulation under oxygen-limitation. 
Intriguingly, on analysis of either the similar locus or similar sequences of the aniS 
gene, we were able to find possible homologous sRNAs in all of the other Neisseria 
genomes available. The regulatory sequence of each suggests an anaerobically 
induced sRNA is synthesised in each species. In fact, the gonococcal AniS 
equivalent has been reported as a highly FNR-induced transcript in a study of the 
gonococcal FNR regulon using a Pan-genome array (Whitehead et al., 2007), 
verifying that AniS is conserved and synthesized in the closely associated pathogen 
N. gonorrhoeae. Interestingly, this study also identified gonococcal mRNAs that 
were repressed by FNR and had no FNR-box in their promoters, nor were they 
enriched by FNR Chromatin immunoprecipitations which, we suggest, may 
represent targets for the gonococcal AniS equivalent (Whitehead et al., 2007). 
Expanding to less similar spp. the conservation of the 3‘ end of each sequence 
including the aSD-like sequence may suggest that these heterologous sequences 
represent regulatory RNAs that function similarly to AniS and may have some 
similar targets for instance NMB0214. The variation of the 5‘ ends of these putative 
sRNA sequences further suggest that distinct targets may exist which are regulated 
through partial complementarity of the heterologous sequences. Indeed, different 
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regions of the FnrS regulator in E. coli were shown to control diverse groups of 
target genes (Durand & Storz, 2010). The conservation during evolution of the 
regulatory regions (FNR-regulated promoter and terminator) and the divergence of 
sequence content highlights the potential versatility of this species of molecule: the 
sRNAs.  
Initially, we hypothesized that the level of AniS was less in the Hfq mutant, as the 
chaperone may play a role in stabilizing the sRNA, as it is known to do with many 
other sRNAs (reviewed in (Valentin-Hansen et al., 2004, Aiba, 2007). However, 
our experiments indicated the contrary to be true for the AniS sRNA, i.e. that Hfq 
enhances the turnover of AniS, since AniS is less stable in Hfq+ background. This 
is of course a surprising finding, but it is not the only case reported. It was recently 
demonstrated, in fact, that in Rhodobacter sphaeroides the sRNA RSs0019 is 
stabilized in the absence of Hfq (Berghoff et al., 2009). Based on the literature the 
contribution of Hfq to sRNA stability is controversial. While it has been shown that 
the binding of this chaperone, in the absence of base-pairing, stabilizes sRNAs 
protecting them from RNAseE cleaveage (Moll et al., 2003; Masse et al., 2003); it 
has also been shown that Hfq-mediated pairing of sRNAs to their targets promotes 
coupled degradation of the interacting RNAs (Masse et al., 2003). Since we showed 
that Hfq is needed to promote the base-pairing interaction of AniS and its targets, 
then Hfq may be promoting the turnover of AniS when there are adequate mRNA 
targets present in the cell. These data suggest that in Neisseria either Hfq is 
involved in the turnover of free AniS, or the turnover of AniS due to base-pairing 
with the target in the Hfq+ background is more rapid than the turnover of the free 
AniS. The short half-life of the AniS in the Hfq+ background (<2 min) is quite 
untypical of many other E. coli sRNAs, including DsrS (Sledjeski et al., 2001), 
RyhB (Moll et al., 2003), OxyS (Basineni et al., 2009, Moller et al., 2002b), Spot 
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42 (Moller et al., 2002), which exhibit long halflives (>30 min) after rifampicin 
treatment. However, some E. coli sRNA are reported as unstable e.g. GcvB has a 
halflife of less than 2 minutes, (Vogel et al., 2003) and recently, the other sRNA of 
meningococcus, NrrF, was reported to have a similar short half-life of 5 min which 
was unvaried in the Hfq mutant (Mellin et al., 2010).  
Since the reduced levels of AniS are not due to increased turnover in the Hfq 
mutant, the Hfq-dependent down-regulation of AniS must be at the level of 
transcriptional initiation. In fact, the microarray Hfq data show that known genes of 
the FNR regulon (namely aniA, and nosR ; (Bartolini et al., 2006) appear to be 
dowregulated in the Hfq mutant, suggesting that Hfq negatively regulates FNR-
mediated transcription, either directly or indirectly, possibly via altered activity of 
the FNR activator in cells lacking Hfq. It was then serendipity that allowed us to 
identify a Hfq-dependent sRNA in this way. This highlights the complexity of the 
effects a Hfq knockout can have on the global transcript profile, suggesting that 
much of the changes in expression will be due to indirect effects of the loss of 
function mutation. Indeed up to 25 % of the transcriptome was altered in Hfq 
mutant in stationary phase (data not shown), and while some direct Hfq/sRNA 
targets may be present in the deregulated genes, other more direct approaches are 
needed to detect and identify other sRNA circuits in the meningococcal and other 
systems for which not a lot is known. 
Recently in E. coli, two independent groups described a similar FNR-regulated 
sRNA, nominated FnrS in line with other sRNA nomenclature, that is induced by 
anaerobiosis and represses the expression of enzymes that are dispensable during 
growth in low oxygen (Durand & Storz, 2010, Boysen et al., 2010). Since it 
exhibits neither sequence similarity nor similar genomic localization to our sRNA 
we have nominated our novel sRNA AniS (anerobically induced sRNA) to 
 100 
distinguish it. It appears therefore that the same stress regulons (FNR-mediated) 
have independently evolved to include a riboregulator in evolutionary diverse 
bacteria. Furthermore, both groups identify numerous targets of FnrS, and 
demonstrate that FnrS is involved in down-regulating genes with aerobic functions 
and genes with housekeeping functions in energy metabolism and biosynthesis that 
are not needed for anaerobic metabolism. While E. coli is a facultative anaerobe, 
which can quite easily adapt its metabolism and grow under complete anerobiosis; 
meningococcus fails to grow under strictly anaerobic conditions but instead has a 
truncated denitrification pathway which allows it to survive anaerobiosis (Anjum et 
al., 2002, Rock & Moir, 2005). This is an important difference between the 2 
systems with respect to the regulatory circuit that they require. The FNR regulon of 
pathogenic Neisseria has been the subject of other studies (Bartolini et al., 2006, 
Whitehead et al., 2007) and notably it is limited to between 10 and 20 genes, in 
contrast to E. coli where FNR acts as a real global regulator coordinating the switch 
from aerobic to anaerobic metabolism and altering the expression of greater than 
200 operons (Constantinidou et al., 2006, Kang et al., 2005, Salmon et al., 2003). 
As such the few targets identified here are in line with the limited need for 
anaerobically induced or repressed genes in meningococcus.  
Nonetheless, N. meningitidis will encounter anaerobic niches as part of its normal 
transmission, colonization and infectious cycles within the host. The surface of the 
upper respiratory tract will have atmospheric oxygen concentration (21kPa). 
However, it should be noted that human mucous membranes, contain areas of low 
partial pressure of oxygen, reported as 400 Pa for the buccal folds (Archibald & 
Duong, 1986) and 300 Pa within a thick mucus layer (Worlitzsch et al., 2002) and 
FNR is activated by oxygen concentrations below 500 Pa (Sawers, 1999).  
Importantly, the FNR mutant of meningococcus is attenuated in the rat and mouse 
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bacteraemia models of infection (Bartolini et al., 2006) highlighting the need for 
sensing and responding to oxygen limitation for survival in vivo.The identification 
of this novel sRNA underpins the need to rapidly co-ordinate gene expression in 
response to changing oxygen environments in the host. In E. coli the FnrS sRNA 
plays a major role in the immediate metabolic need of adapting to anaerobic growth 
(Durand & Storz, 2010, Boysen et al., 2010). The regulation by AniS may have 
more to do with a coordinated response to an anaerobic environment as a specific 
niche-relevant signal requiring adaptive physiological changes for meningococcus 
an exclusively human host-adapted pathogen. 
 
1.27 Molecular mechanism of action of the sRNA NrrF 
In this section we have characterized the molecular mechanism of action of the 
sRNA NrrF in N. meningitidis. NrrF was discovered in 2007 ((Mellin et al., 2007)) 
as an iron regulated sRNA which post-transcriptionally downregulates the succinate 
dehydrogenase genes (Mellin et al, 2007; Metruccio et al, 2009). In this thesis we 
have shown that Hfq is able to bind NrrF in vitro and increases the efficiency of 
NrrF duplex formation with the complementary target region within the sdh 
transcript (Fig 25). Numerous E. coli sRNAs have been shown to associate with 
Hfq (Majdalani et al., 2005; Valentin-Hansen et al, 2004) and we showed that in N. 
meningitidis also AniS requires Hfq to down regulate its targets (Fig 20). The 
complementarity between NrrF and its target sequence lies within an accessible 
single-stranded loop of the predicted structure of NrrF possibly facilitating initial 
contact, which Hfq may then enhance or stabilize through its RNA chaperone 
activity. In fact we showed that removing this loop from the NrrF transcript the 
interaction with the sdh target does not occur anymore (Fig 25B, panel III). It is 
likely that the formation of the complex between NrrF and sdh transcript in vivo 
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results in the rapid degradation of the target mRNA, possibly as a consequence of 
inhibition of translation. It is clear from in vitro binding assays, that NrrF directly 
targets the sdh transcript not in the 5‘UTR region, as usual for sRNAs, but 
overlapping the sdhDA gene junction between the second and third gene (Fig. 25B).  
It was reported that sRNAs can also interact with coding regions (Pfeiffer et al., 
2009), regulating their targets by accelarating RNase E-dependent mRNA targets 
decay. Furthermore in E. coli a NrrF analogous sRNA, RyhB, with no sequence 
identity nor genomic synteny, was reported to down-regulate the succinate 
dehydrogenase operon through base pairing within a proposed region of 
complementarity at the junction of the first and second gene in the locus, sdhCD 
(Massè & Gottesmann, 2002). It is intriguing that in two completely different 
systems the conserved mechanism for regulating these metabolic genes has evolved 
in two apparently non-homologous but essentially similar mechanistic events. 
Conceptually, sRNAs are expected to be under appropriate transcriptional control, 
so that their induction matches requirements for their regulatory activity. Our data 
are consistent with a model in which high expression and abundance of NrrF in low 
iron conditions (or in the Fur mutant), results in a Hfq-dependent targeting of the 
sdh transcript, a NrrF-dependent translational inhibition of SdhA, and likely rapid 
degradation of the mRNA. In this way, the succinate dehydrogenase genes are 
essentially positively regulated through the repressive action of Fur with iron as a 
co-repressor.  
Furthermore we show that the Fur- and iron- positive regulation of at least two 
other genes, sodB and fumB are clearly through a Hfq-dependent mechanism, 
although the NrrF sRNA is excluded as mediator (Fig 26). The expression of SodB 
was aslo found negatively regulated in a Hfq knock out mutant (Table 1). These 
data implicate at least one other trans-acting sRNA to be involved in the post-
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transcriptional down- regulation of sodB and fumB, and possibly also sdh. It is 
therefore likely that more than one Fur-regulated sRNA is present in the Neisseria 
system and Solexa RNA sequencing data revealed the existence of 16 putative iron 
regulated sRNAs. It will be interesting to characacterize these putative novel 
sRNAs and to undersatnd if NrrF, along with one or more other sRNAs, control 
coordinately some of the remaining Fur-positively regulated genes in 
meningococcus. We also cannot exclude the possibility that other mRNAs are 
targets for the NrrF regulator. In fact in N. meningitidis a subset of genes that are 
positively regulated by Fur and iron, with no evidence for a direct interaction of Fur 
in their region, were identified (Delany et al, 2006) and therefore candidate genes 
for this type of indirect posttranscriptional riboregulation. Many organisms respond 
to iron deprivation by rearranging their metabolism to bypass iron-dependent 
enzymes, such as sodB and the tricarboxylic acid cycle enzymes such succinate 
dehydrogenase and fumarase, and to dispense with iron-binding proteins, such as 
ferritins. In E. coli the role of a sRNA, RyhB, in mediating this change in 
metabolism was the first to be documented (Massè & Gottesmann, 2002). In 
Pseudomonas two tandem small RNAs were found to be responsible for mediating 
a similar RyhB-like posttranscriptional regulation (Wilderman et al., 2004). 
Deletion of both of these analogues was necessary for deregulation of a number of 
iron and Fur induced genes although their findings also demonstrate that the PrrF 
RNAs do not explain all positive Fur regulation in Pseudomonas.  
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1.28 CONCLUDING REMARKS  
The discovery of small noncoding RNAs (sRNAs) as modulators of stress 
adaptation and virulence gene expression, coordinating complex networks in 
response to environmental cues, has brought a new insight into regulation of 
bacterial pathogenesis processes (reviewed in (Toledo-Arana et al., 2007; Papenfort 
& Vogel, 2010; Gripenland et al., 2010). In the human pathogen N. meningitidis we 
have demonstrated that the Hfq mutant displays a pleiotropic phenotype and 
identified and characterized 2 novel sRNAs. Furthermore a transcriptome analysis 
under iron replete or depleted conditions through Solexa RNA sequence revealed 
19 intergenic regions actively transcribed in these two conditions. 
Taking together these data strongly indicate that there is an extensive circuit of 
sRNA genes involved in adaptation to stress and pathogenesis in meningococcs as 
yet largely unexplored.  
The identification and characterization of novel sRNAs in this bacterium will help 
in understanding the mechanisms of pathogenesis of N. meningitidis and the 
finetuning of regulatory and adaptive responses.. 
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MATERIALS AND METHODS 
 
 
1.29 Bacterial strains and culture conditions 
The meningococal strains used in this study are all derivatives of the N. 
meningitidis MC58 sequenced strain (Tettelin et al., 2001) and 2996 strain. N. 
meningitidis strains were routinely cultured in GC-based (Difco) agar medium 
supplemented with Kellogg‘s supplement I (Kellogg et al., 1963) at 37°C in a 5% 
CO2–95% air atmosphere with 95% humidity. Stock preparations of strains in 10% 
skim milk were stored at -80°C. Each bacterial manipulation was started using an 
overnight culture of a frozen stock. For liquid cultures N. meningitidis strains were 
grown overnight on solid medium, and cells were resuspended in 
phosphatebuffered saline (PBS) to an optical density at 600 nm (OD600) of 1 and 
inoculated into broth medium at a 1:100 dilution. GC (Difco) broth supplemented 
with Kellogg‘s supplement I and 12.5 M Fe(NO3)3 and Mueller-Hinton (Sigma, 
St.Louis, MO) broth supplemented with 0.2% glucose were used for liquid cultures; 
when required, erythromycin, chloramphenicol, kanamycin or IPTG were added to 
final concentrations of 5 g/ml, 5 g/ml, 100 g/ml, and 1mM respectively. For 
transformation by naturally competent N. meningitidis, four to five single colonies 
of a freshly grown overnight culture were re-suspended in 20 l of PBS, spotted 
onto GC plates, and 5–10 µg of linearized plasmid DNA was added, allowed to dry 
and incubated for 6–8 h at 37°C. Transformants were then selected on plates 
containing the appropriate antibiotic and single colonies were re-streaked on 
selective media for further analysis. Transformants were re-suspended in 50 µl of 
distilled water, placed in a boiling water bath for 5 min and centrifuged in a bench 
top centrifuge for 5 min at 8000 g. One microlitre of the sample was used as 
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template for PCR analysis for correct insertion by a double homologous 
recombination event. E. coli cultures were grown in Luria-Bertani medium, and, 
when required, ampicillin was added to a final concentration of 100 g/ml. 
 
1.30 DNA techniques 
DNA manipulations were carried out routinely as described by (Sambrook et al., 
1989). Small- and large-scale plasmid DNA preparations were carried out with a 
QIAprep Spin Mini kit and Plasmid Midi kit (QIAGEN) according to the 
manufacturer‘s instructions. DNA fragments or PCR-amplified products were 
purified from agarose gels with QiaEX DNA purification kit (QIAGEN). PCR was 
performed in a Perkin-Elmer 2400 thermal cycler with Platinum Taq polymerase 
(Invitrogen). One microlitre of each reaction mixture contained 10–50 ng of 
chromosomal DNA or 1 µl bacterial sample (see above), 100 pmols of the required 
primers and 200 µM concentration of each deoxynucleotide in a volume of 100 µl 
of 1 x PCR buffer containing MgCl2 (Invitrogen). After the initial denaturing step 
at 95°C for 5 min, 30 cycles of denaturing at 95°C, annealing at the appropriate 
temperatures for the specific primers and elongation at 72°C were carried out. 
When required, DNA fragments were routinely sequenced according to the 
dideoxy-chain termination method (Sanger et al., 1977) by using [-32P]-dATP 
(NEN, Perkin Elmer) and a T7 sequencing kit (Pharmacia). 
 
1.31 Construction of plasmids and recombinant strains 
In order to knock out the hfq gene in the MC58 background, the phfqko:Cm or 
phfqko:Kan plasmids were constructed. Upstream and downstream flanking 
regions of the hfq gene were amplified by PCR with primers Hfq-1 and Hfq-2 and 
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primers Hfq-3 and Hfq-4 (Table 5), respectively. Then in a second round of PCR 
the upstream and downstream fragments, which contained regions of overlap due to 
the design of the primers, were used for self-priming PCR amplification for five 
cycles, and the united fragment was amplified using external primers Hfq-1 and 
Hfq-4. The product was cloned into the pGEM-T (Promega) vector, and a 
chloramphenicol cassette from pDT2548 (Wang & Taylor, 1990)or a kanamycin 
resistant gene from pill600 (Labigne-Roussel et al., 1988)  were inserted into the 
BamHI site between the flanking regions, generating phfqko:Cm or phfqko:Kan, 
respectively. These plasmids were then linearized and used for transformation. The 
phfqko:Kan plasmid was used to transform the  MC58 strain to make hfqkan  
strain, while the  phfqko:Cm plasmid was used to transform MC58 and 2996 
strains to make hfq and 2996hfq mutants, respectively and MC-Fko (Delany et 
al., 2003) to make a Fur and Hfq double mutant, Fko-hfq . For complementation 
of the knockout, a plasmid consisting of the ermAM erythromycin resistance genes 
and the Ptac promoter along with the lacI repressor for isopropyl--D-
thiogalactopyranoside (IPTG)-inducible expression of the gene of interest, flanked 
by upstream and downstream regions for allelic replacement, was generated by 
replacing the 3.4-kb NotI-BamHI fragment carrying the promoterless lacZ gene 
from pSL-Fla-Ery (Ieva et al., 2005) with a 1.6-kb NotI-BamHI fragment carrying 
the lacI repressor gene and the Ptac promoter from plasmid pPindCrgA (Ieva et al, 
2005), generating pFlaEry-Pind. The hfq coding region was amplified with primers 
Hfq-F and Hfq-R-Ns and cloned as a 303-bp NdeI-NsiI fragment downstream of 
the Ptac promoter, generating pFlaPind-Hfq, so that expression of the hfq gene in 
the complementation construct was induced in an IPTG-inducible manner. This 
 108 
plasmid was used for transformation of the hfq mutant strain, and the resultant 
complemented mutant was designated hfq_C. 
In order to knock out the aniS gene, by substituting the nucleotides spanning from –
45 to +112 with respect to the transcriptional start site with a kanamycin cassette, 
the psR3:Kan plasmid was constructed. Upstream and downstream flanking 
regions of the aniS gene were amplified by PCR with the corresponding primers: 
sR3-1/sR3-2 and sR3-3/sR3-4 (Table 5). Then, the same strategy used for the 
construction of the phfqko:Kan plasmid  was used, generating psR3:Kan 
plasmid. The plasmid was then linearised and used for transformation of the MC58 
strain to make a aniS knockout mutant, aniS. 
To generate recombinant MC58, aniS and hfqkan derivative strains expressing a 
FNRD148A protein from an integrated copy of the mutant gene, the plasmid 
pCompIndfnr(D148A) (Oriente et al., 2010) which results in integration of a copy 
of the mutant allele fnr(D148A) under the control of the Ptac promoter between the 
NMB1428 and NMB1429 genes, was transformed into MC58, aniS and hfqkan 
strains, generating MC_FNRC, aniS_FNRC and hfq_FNRC strains respectively. 
To knock out the nrrF gene plasmid psRN2ko:Erm was generated amplifying 
upstream and downstream flanking regions of the nrrF gene by PCR with the 
corresponding primers: UsR-F/ UsR-R and DsR-F/ DsR-R (Table 5) and following 
the same strategy used above to generate plasmids for knockout strains, but using 
an erythromycin cassette (Trieu-Cuot et al., 1990). The psRN2ko:Erm plasmid was 
then linarized and used to transform MC58 and MC-Fko (Delany et al, 2003) 
strains to make respectively a NrrF knockout mutant, MC-sRN2, and a Fur and 
NrrF double mutant, Fko-sRN2. The Fur complemented strain, Fko_C, was 
constructed as described in Delany et al, 2003. 
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In each case case transformants were first isolated by selection for the respective 
antibiotic resistance and then tested for the double crossover in the flanking regions 
by PCR. 
To study the AniS-mediated regulation of NMB1468 we used the green fluorescent 
protein (GFP)-based reporter system developed by Urban and Vogel (Urban & 
Vogel, 2007). The 5‘ end of the NMB1468 gene, including 213 nt of the upstream 
region, was amplified by PCR on MC58 genome using primers 1468-pr-F/1468-
gfp-R and cloned into pXG-10 as a AatII/NheI fragment, so that the first 10 amino 
acids were fused to GFP and the PLtetO promoter was removed form pXG-10 and 
replaced by NMB1468 promoter, generating pXG-10-1468 plasmid. To generate 
pGemT-AniS plasmid PCR was performed on MC58 genome using primers AniS-
pr/AniS-R and the resultant product, containing the aniS gene, and 144 nt upstream 
of the +1 was cloned into pGEMT as a compatible plasmid for co-transformation 
with pXG-10-1468. pGEMT- plasmid, was also generated as a negative control for 
AniS , cloning into pGEMT the NMB0375 promoter region amplified by PCR on 
MC58 genome using primers P375-F/ P375-R. E. coli DH5-cells were co-
transformed either with pXG-1 plasmid, as a control for GFP expression, or pXG-
10-1468 plasmid and pGemT-AniS or pGEMT-. 
 
1.32 Expression and purification of the Hfq protein. 
The hfq gene was amplified from the MC58 genome with the Hfq-F/Hfq-R primer 
pair and cloned as a 302-bp NdeI-XhoI fragment into the pET15b expression 
plasmid (Invitrogen), generating pET15hfq, which was subsequently transformed 
into E. coli strain BL21(DE3) for protein expression. Using an overnight culture of 
the BL21(DE3)(pET15hfq) strain, 200 ml of Luria-Bertani medium was inoculated, 
the culture was grown until the OD600 was 0.5, and expression of the recombinant 
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Hfq protein containing an N-terminal histidine tag was induced by addition of 1 
mM IPTG and further incubation for 3 h. The protein was purified from the 
harvested cells by Ni-nitrilotriacetic acid (NTA) (Qiagen) affinity chromatography 
under nondenaturing conditions according to the manufacturer‘s instructions. The 
purified protein preparation was then diluted to 1 g/l and dialyzed overnight in 
PBS at 4°C. To remove the His tag, the dialyzed protein was digested with 
thrombin (10 U/g protein; Pharmacia/Amersham) at room temperature for 4 h, and 
the thrombin was then deactivated by incubation with 1 mM of 
phenylmethylsulfonyl fluoride at 37°C for 15 min. The digested His tag was 
removed by dialyzing the protein preparation twice against 1 liter of PBS at 4°C in 
a 6,000- to 8,000-molecular-weight-cutoff dialysis tube (Membrane Filtration 
Products, Inc.). The purity of the protein was estimated to be 99% by SDSPAGE. 
The concentration of the protein in this preparation was determined by using the 
Bradford colorimetric assay (Bio-Rad), and the protein was aliquoted and stored at 
-80°C. 
 
1.33 In vitro cross-linking 
For in vitro cross-linking, the dialyzed Hfq protein was diluted to obtain a 
concentration of 0.6 g/l in PBS. Disuccinimidyl suberate (DSS) was added to 10 
l of the protein solution to a final concentration of 2.5 mM, and this was followed 
by incubation at room temperature for 1 h. To stop the cross-linking reaction, 20 l 
of 1xSDS-PAGE loading buffer (50 mM Tris Cl pH 6.8, 2.5 % SDS, 0.1 % 
Bromophenol Blue, 10% glycerol, 5% B-mercapto-Ethanol, 50 mM DTT) was 
added, and the protein was analyzed by SDS-PAGE. 
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1.34 Generation of anti-Hfq antiserum 
To prepare anti-Hfq antiserum, 20 g of purified protein was used to immunize 6-
week-old female CD1 mice (Charles River Laboratories); four mice were used. The 
protein was given intraperitoneally, together with complete Freund‘s adjuvant for 
the first dose and incomplete Freund‘s adjuvant for the second (day 21) and third 
(day 35) booster doses. Bleed-out samples were taken on day 49 and used for 
Western blot analysis. 
 
1.35 Western blot analysis 
N. meningitidis colonies from overnight plate cultures were either resuspended in 
PBS until OD600 of 1, or grown to logarithmic phase (OD of 0.5, ca. 2 hours 
incubation) from a starter inoculum of OD 0.05. Samples of 1-2 ml were harvested 
and normalised in 1xSDS-PAGE loading buffer to a relative OD of 5. For Western 
blot analysis, 10 g of each total protein sample in 1 x SDS-PAGE loading buffer 
was separated by SDS-PAGE, and transferred onto nitrocellulose membrane using 
an iBlot Dry Blotting System (Invitrogen). Membranes were blocked overnight at 
4C° by agitation in blocking solution (10% skimmed milk, 0.05% Tween-20, in 
PBS) and incubated for 90 min at 37°C with the appropriate polyclonal sera in 
blocking solution. After washing, the membranes were incubated in a 1:2000 
dilution of peroxidase-conjugated anti-rabbit immunoglobulin (Biorad) or anti-
mouse immunoglobulin (Dako), in blocking solution for 1 hour and the resulting 
signal was detected using the Supersignal West Pico chemiluminescent substrate 
(Pierce).  
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For E. coli GFP, Western Blots 10 ug of cell extracts from E. coli plate cultures 
were separated by SDS-PAGE and after blotting, filters were stained with 1:1000  
dilution of anti-GFP (SantaCruz Biotechnologies,Inc). 
 
 
1.36 Fractionation of proteins of N. meningitidis 
Liquid cultures of meningococcus strains were grown to an OD600 of 0.5 and 
harvested by centrifugation at 8,000 g for 15 min at 4°C. Secreted proteins were 
precipitated from each spent culture supernatant as follows. The supernatant was 
filtered through a 0.22-m filter to remove bacteria, and to 22 ml of the filtrate 2.5 
ml of 100% trichloroacetic acid (Sigma) was added and incubated overnight on ice. 
The precipitated proteins were then pelleted in a benchtop centrifuge (Beckman) at 
13,000 rpm for 30 min at 4°C and washed with 500 l of 70% ethanol, and the 
pellet was then air dried and resuspended in 10 l of PBS containing complete 
protease inhibitor (Roche). For cytoplasmic and envelope fractions, harvested 
bacteria were resuspended in PBS and inactivated at 56°C for 45 min. The cells 
were then repelleted by centrifugation at 8,000 g for 15 min at 4°C and resuspended 
in 20 mM Tris-HCl (pH 7.5) containing complete protease inhibitor. The bacteria 
were lysed by sonication on ice, and the cell debris was removed by centrifugation 
at 5,000  g for 20 min. The supernatant was centrifuged at 50,000 g for 75 min 
(29,000 rpm; Beckman Ti50) to pellet the membrane fraction. The supernatant, 
containing the soluble cytoplasmic fraction, was then filtered and analyzed by SDS-
PAGE. The pellet containing the membrane envelope was washed with 5 ml of 20 
mM bis-Tris propane (pH 6.5), 1 M NaCl, 10% glycerol and then pelleted by 
centrifugation at 50,000 g for 75 min. The membrane fraction was resuspended in 
PBS and analyzed by SDS-PAGE.  
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1.37 Separation of total proteins by 2D gel electrophoresis.  
N. meningitidis wildtype strain MC58 and the hfq mutant were grown at 37°C in 
GC medium until the OD600 was 0.5 to 0.6. The cells were harvested, washed once 
in PBS, and heat inactivated for 2 h at 65°C. Bacteria were resuspended in 
reswelling buffer containing 7M urea, 2M thiourea, 2% 3-[(cholamidopropyl)-
dimethylammonio]-1-propanesulfonate (CHAPS), 2% amidosulfobetain 14, 1% 
dithiothreitol, 2 mM tributylphosphine, 20 mM Tris, and 2% carrier ampholyte (GE 
Healthcare), and 200 g of total proteins in 0.125 ml (final volume) was absorbed 
overnight onto Immobiline DryStrips (7 cm; nonlinear pH 3 to 10 gradient) using 
an Immobiline DryStrip reswelling tray (GE Healthcare). Proteins were then 
separated by two-dimensional (2D) electrophoresis. The first dimension was run 
using an IPGphor isoelectric focusing unit (GE Healthcare) by sequentially 
applying 150V for 60 min, 500 V for 35 min, 1,000 V for 30 min, 2,600 V for 10 
min, 3,500 V for 15 min, 4,200 V for 15 min, and finally 5,000 V until 12,000 V · h 
was reached. For the second dimension, the strips were equilibrated as described 
previously (Herbert et al, 1998), and proteins were separated on a Nu-Page 4 to 
12% bis Tris ZOOM gel (Invitrogen) using 40 mA/gel. An image of each 
bidimensional gel was acquired with an SI personal densitometer (Molecular 
Dynamics) at 16 bits and 50 m per pixel. Images were analyzed with the software 
Image Master 2D Platinum 6.0 (GE Healthcare). 
 
1.38 In-gel protein digestion and MALDI-TOF mass spectrometry 
analysis 
 Protein spots were excised from the gels, washed with 50 mM ammonium 
bicarbonate-acetonitrile (50/50, vol/vol), and air dried. Dried spots were digested 
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for 2 h at 37°C in 12 l of 0.012-g/l sequencing grade modified trypsin 
(sequencing grade modified porcine trypsin; Promega, Madison, WI) in 5 mM 
ammonium bicarbonate. After digestion, 0.6 l was loaded on a matrix-prespotted 
Anchorchip (PAC 384 HCCA; Bruker-Daltonics, Bremen, Germany) and air dried. 
Spots were washed with 0.6 l of a solution containing 70% ethanol and 0.1% 
trifluoroacetic acid. Mass spectra were acquired with an ultraflex matrix-assisted 
laser desorption ionization—time of flight (MALDI-TOF) mass 
spectrometer(Bruker-Daltonics). Spectra were externally calibrated by using the 
combination of standards present on the PAC chip (Bruker-Daltonics). 
Monoisotopic peptide matching and protein searching were performed 
automatically using a licensed version of the MASCOT software (Matrix Sciences, 
London, United Kingdom) run on a local database. The MASCOT search 
parameters used were as follows: (i) allowed number of missed cleavages, 1; (ii) 
variable posttranslational modification, methionine oxidation; and (iii) peptide 
tolerance, ±100 ppm. Only significant hits as defined by MASCOT probability 
analysis were considered. 
 
1.39 In vitro antimicrobial stress assays 
To investigate the sensitivities of the hfq mutant strain to various stresses, a series 
of growth assays and killing assays were performed using different antimicrobial 
compounds. Unless otherwise stated, the hfq_C complemented mutant was 
cultured in the presence of 1 mM IPTG for induction of hfq gene expression. 
Membrane integrity was investigated by looking at the susceptibility to osmotic 
stress (30% sucrose and 5MNaCl) and detergents (0.01 to 0.05% Tween and 
sodium dodecyl sulfate [SDS]). To investigate the responses of the strains to 
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oxidative stress, paraquat (5 to 10 mM; Sigma), xanthine-xanthine oxidase (4.3 mM 
xanthine and 100 to 300 mU/ml xanthine oxidase; Sigma), and H2O2 (5 to 10 mM; 
Riedel-de Haen) killing assays were performed. For killing assays, cells from GC 
agar plates were harvested into GC media to obtain an OD600 of 0.05, grown to 
mid-log phase (OD600, 0.5 to 0.6), and then diluted to obtain a concentration of 
105 to 106 CFU/ml. The killing assay was started by addition of the killing sample. 
Cultures were incubated at 37°C in an atmosphere containing 5% CO2 with gentle 
agitation, and at various time points samples were taken, plated onto Mueller-
Hinton agar after serial dilution, and incubated at 37°C in an atmosphere containing 
5% CO2 to determine the number of CFU. Experiments were done in triplicate and 
repeated on several occasions. 
 
1.40 Ex vivo human serum assay and ex vivo whole-blood model of 
meningococcal bacteremia. 
N. meningitidis strains were grown on GC agar overnight. Cells were harvested into 
Mueller-Hinton medium containing 0.25% glucose and 0.02 mM cytidine-5‘-
monophospho-N-acetylneuraminic acid sodium salt to obtain an OD600 of 0.05, 
grown to mid-log phase (OD600, 0.5 to 0.6), and then diluted to obtain a 
concentration of approximately 103 CFU/ml. The assay was started by addition of 
100% whole human blood or human serum (240 l) to the bacterial suspension (10 
l). Cultures were incubated at 37°C in an atmosphere containing 5% CO2 with 
gentle agitation, and at various time points an aliquot was removed and the number 
of viable bacteria was determined by plating serial dilutions onto Mueller-Hinton 
agar and incubating the plates overnight at 37°C in an atmosphere containing 5% 
CO2. Experiments were done in triplicate and repeated on several occasions. Whole 
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venous blood, collected from healthy individuals and anticoagulated with heparin 
(10 U/ml), was used for whole-blood experiments. For preparation of human serum, 
whole blood was coagulated at 37°C for 30 min and centrifuged at 1,000  g for 10 
min at 4°C, and the supernatant was retained. Statistical analyses of the differences 
between the survival of the wild type strain and the survival of mutant strains were 
performed using Student‘s t test. 
 
1.41 In vivo animal model. 
The infant rat model was used essentially as previously described (Granoff et al., 
2001). The 2996 N. meningitidis strain was passaged three times in infant rats. On 
the day of the experiment the bacteria were grown to log phase in Mueller-Hinton 
medium supplemented with 0.25% glucose, washed, and resuspended at the desired 
concentration in PBS. Five- to 6-day-old pups from litters of outbred Wistar rats 
(Charles River) were challenged intraperitoneally with wild type strain 2996 or the 
isogenic 2996hfq strain. Eighteen hours after the bacterial challenge, blood 
specimens were obtained by cheek puncture, and aliquots (100 l of undiluted sera 
and 1:10, 1:100, and 1:1,000 dilutions) were plated onto chocolate agar for viable 
cell counting. The numbers of CFU per milliliter of blood were determined after 
overnight incubation of the plates at 37°C in an atmosphere containing 5% CO2. A 
statistical analysis was performed using Student‘s t test. 
 
1.42 RNA extraction 
N. meningitidis strains were routinely grown in 16 ml tubes in 7 ml of liquid culture 
to mid-log phase and then added to an equal volume of the same frozen medium to 
bring the temperature immediately to 4°C and centrifuge at 3000 g for 20 minutes. 
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RNA was extracted from the pellet using the RNAeasy Mini-kit (Qiagen) or SV 
RNA isolation kit (Promega) for Illumina sequecing . RNA pools for microarray 
experiments were prepared from 3 independent cultures of bacteria. Briefly, for 
each RNA pool, 3 independent cultures of each strain were grown to mid-log phase 
and total RNA was extracted separately from each bacterial pellet and 15 ug of 
each preparation were pooled together. Three independent pools were prepared for 
each strain. For the oxygen limiting conditions, liquid cultures, once grown to mid-
log phase, were first diluted to OD 0.1 and split into 7 ml (microaerobic growth, 
+O2 ) or 15 ml (oxygen limiting conditions,-O2) in 16 ml tubes, re-incubated at 
37°C for 30 min, and then added to an equal volume of frozen media and RNA was 
extracted. For the iron limiting conditions, liquid cultures grown to mid-log phase 
were split in two and exposed for 15 min treatment with or without 100 μM 2,2‘-
dipyridyl (specific iron-chelator) (Sigma). After 15 min the cultures were added to 
an equal volume of equivalent frozen medium and RNA was extracted. For the 
rifampicin timecourse, a culture of 100 ml was grown in Erlenmeyer flasks under 
microaerobic conditions until log phase and then 80 ug/ml of rifampicin were 
added and, at indicated times, 15 ml were removed and added to an equal volume 
of frozen medium. RNA was extracted by CsCL gradient as previously described 
(Metruccio et al., 2009). 
 
1.43 Microarray procedures: design, cDNA labelling and 
hybridization, and data analysis. 
DNA microarray analysis was performed using an Agilent custom-designed 
oligonucleotide array. Design: A 60-mer oligo-microarray was designed to cover all 
the 2078 predicted open reading frames of N. meningitidis MC58 strain. Probe 
design was performed respecting oligo sequence specificity, structural and 
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thermodynamic constraints in order to obtain at least two probes for each open 
reading frame of the genome. For some specific genes we covered the entire open 
reading frame with head to tail tiling with a 10 nucleotide overlap (fHbp, nadA, 
NMB2132, NMB1030; NMB2091). Two probes for each of the previous selected 
genes together with the seven multi locus typing housekeeping genes, abcZ, adk, 
aroE, fumC, gdh, pdhC and pgm were used for the design of 21 and 5 replicas 
randomly distributed on the surface of the chip to have control spots of the signal 
uniformity within each sample. cDNA probes were prepared from RNA pools (5 
ug) using Superscript II reverse transcriptase (Invitrogen), random primers 
(Promega), and Cy5 and Cy3 dyes (Amersham Biosciences). Labeled cDNA was 
purified by using a QIAquick PCR purification kit (Qiagen). The efficiency of 
incorporation of the Cy5 or Cy3 dyes was measured by NanoDrop analysis. Equal 
amounts of Cy5- and Cy3 labeled cDNAs were hybridized onto the microarray for 
17 h at 65°C according to the Agilent protocol. Three hybridizations were 
performed using cDNA probes from 3 independent pools, respectively, 
corresponding to RNA extracted from a total of 9 independent bacterial cultures for 
each strain. Images were acquired by using an Agilent microarray scanner G2505B 
at 5 μm of resolution and using the extended dynamic range and were analyzed 
with Agilent Feature Extraction 9.5.1. Extracted raw data were normalized with the 
BASE application using an intra-slide median centering after a low intensity spot 
correction (if the average spot intensity, background subtracted, is less than one 
standard deviation of the background signal, the spot intensity was corrected to the 
same value of one standard deviation of the background signal). Differentially 
expressed genes (exhibiting a fold change of at least 2 with respect to the reference) 
were assessed by grouping all log2 ratio of the Cy5 and Cy3 values corresponding 
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to each gene, within experimental replicas and spot replicas, and comparing them 
against the zero value by Student‘s t-test statistics (one tail). 
 
1.44 Primer extension, S1 nuclease mapping, Northern blot and 
real time PCR 
Primer extension was performed as previously reported (Delany et al., 2003). To 
ensure correct mapping of the promoter sequencing reaction was carried out with a 
T7 sequencing kit (USB Corporation) using the same primer as in the primer 
extension reactions and the plasmid consisting of the relevant cloned promoter. 
A radioactively labeled DNA probe for S1 mapping of the 5‘ region of the hfq 
transcript from position +1 was prepared as follows. The probe was amplified from 
the MC58 chromosome using the Hfq-S1/Hfq-S2 primer pair, the appropriate 363-
bp fragment was extracted from an agarose gel, and after purification 2 pmol of the 
probe was labeled at both extremities with T4 polynucleotide kinase and 4 pmol of 
[-32P]ATP. One labeled extremity was removed by digestion with EcoRI, a site 
for which was incorporated into the upstream primer (Hfq-S1), and the resultant 
345-bp probe, labeled on the 5‘ complementary strand, was purified using 
Chomaspin TE-100 columns (Clontech). Approximately 20 fmol of labeled probe 
was coprecipitated with 15 g of total RNA and resuspended in 20 l of 
hybridization buffer (80% formamide, 60 mM Tris-HCl [pH 7.5], 400 mM NaCl, 
0.4 mM EDTA). The mixture was overlaid with 5 l of paraffin oil, denatured at 
100°C for 3 min, and then incubated at the melting temperature (Tm) calculated for 
the probe on the basis of the following formula: Tm  81.5 + 0.5(G+C content) + 
16.6(natural log of Na concentration) - 0.6(formamide concentration expressed as a 
percentage). After 4 to 16 h of hybridization, 180 l of ice-cold S1 buffer (33 mM 
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Na acetate [pH 5.2], 5 mM ZnSO4, 250 mM NaCl) and 100 U of S1 nuclease 
(Invitrogen) were added, and S1 nuclease digestion was carried out for 30 min at 
37°C. Samples were then extracted once with phenol-chloroform, ethanol 
precipitated, resuspended in 5 l sequencing loading buffer (Sambrook et al, 1989), 
and subjected to 6% urea-polyacrylamide gel electrophoresis (PAGE). 
Quantification of the signals from the digested probes was performed using a 
Phosphorimager and ImageQuant software (Molecular dynamics). A G-A 
sequencing reaction (Maxam & Gilbert, 1977) was performed with the probe 
parallel to the S1 nuclease reactions to provide a molecular weight ladder for 
mapping the 5‘ end of the transcript. 
Northern blot analysis to identify the AniS transcript was carried out using the 
NorthernMax kit (Ambion, Inc.) according to the manufacturer's instructions. A 
total of 5 μg of total RNA from different N. meningitidis samples was fractionated 
on a 1% agarose-formaldehyde gel or denaturing 10% polyacrylamide urea gel 
(10% TBU gel, Invitrogen) and transferred onto nylon membrane (Hybond+, Inc.) 
through capillary blotting or electro-blotting (45 min, 150mA,) in a semi-dry blotter 
(Thermo scientific). Then, 2 pmol of a 304-bp PCR product amplified from the 
MC58 genome using the primers 1205-F and 1205-R was radioactively end labeled 
by using T4 polynucleotide kinase (New England Biolabs) and [ -32P]ATP (Perkin-
Elmer) and was used as probe. Hybridization and high stringency washes steps 
were performed at 42°C, low stringency washes at room temperature.  
For real-time quantitative PCR (RT-PCR), approximately 4 μg of total RNA was 
treated with RQ1 RNase-free DNase (Promega). RNA was then reverse transcribed 
using random hexamer primers and Moloney murine leukemia virus reverse 
transcriptase (Promega) as recommended by the manufacturer. For negative 
controls, all RNA samples were also incubated without reverse transcriptase. All 
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RT-PCRs were performed in triplicate using a 25-μl mixture containing cDNA (5 
μl of a 1/5 dilution), 1x brilliant SYBR green quantitative PCR master mixture 
(Stratagene), and approximately 5 pmol of each primer (Table 5).  Amplification 
and detection of specific products were performed with an Mx3000 real-time PCR 
system (Stratagene) using the following procedure: 95°C for 10 min, followed by 
40 cycles of 95°C for 30 s, 55°C for 1 min, and 72°C for 30 s and then a 
dissociation curve analysis. The 16S rRNA gene was used as the endogenous 
reference control, and relative gene expression was determined using the 2
Ct
 
relative quantification method.  
 
1.45 cDNA library construction and Illumina sequencing 
RNA was extracted using SV RNA isolation kit (Promega) not to loose small RNA 
transcripts. RNA quality was determined using Bioanalyser (Agilent) and 
quantified using Nanodrop. Genomic DNA was removed with two digestions using 
30 U DNAseI (Roche) at 37°C to below PCR-detectable levels. RNA was reverse 
transcribed using randomprimers (Invitrogen) and Superscript III (Invitrogen) at 
45°C for three hours and heat denatured at 70 C for 15 minutes. Highly transcribed 
genes fhbp, nhba and kat with a maximum amplicon of 250 bp, were used as targets 
for a PCR as a positive control for reverse transcription. Sequencing libraries for 
the Illumina GAI platform were constructed by shearing the enriched cDNA by 
nebulisation (35psi, 6 min) followed by end-repair with Klenow polymerase, T4 
DNA polymerase and T4 polynucleotide kinase (to blunt-end the DNA fragments). 
A single 39 adenosine moiety was added to the cDNA using Klenow exo- and 
dATP. The Illumina adapters (containing primer sites for sequencing and flowcell 
surface annealing) were ligated onto the repaired ends on the cDNA and gel-
electrophoresis was used to separate library DNA fragments from unligated 
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adapters by selecting cDNA fragments between 200–250 bps in size. 
Fragmentation followed by gelelectrophoresis were used to separate library DNA 
fragments and size fragments were recovered following gel extraction at room 
temperature to ensure representation of AT rich sequences. Ligated cDNA 
fragments were recovered following gel extraction at room temperature to ensure 
representation of AT rich sequences. Libraries were amplified by 18 cycles of PCR 
with Phusion polymerase. Sequencing libraries were denatured with sodium 
hydroxide and diluted to 3.5 pM in hybridisation buffer for loading onto a single 
lane of an Illumina GA flowcell. Cluster formation, primer hybridisation and 
single-end, 36 cycle sequencing were performed using proprietary reagents 
according to manufacturers‘ recommended protocol (https://icom.illumina.  com/). 
The efficacy of each stage of library construction was ascertained in a quality 
control step that involved measuring the adapter-cDNA on a Agilent DNA 1000 
chip. A final dilution of 2 nM of the library was loaded onto the sequencing 
machine. 
 
1.46 Read mapping and visualization 
For RNA-seq experiments the computational pipeline developed at the 
WellcomeTrust Sanger Institute, (http://www.sanger.ac.uk/Projects/ 
Pathogens/Transcriptome/) was used to the process the raw data.  All reads to the 
MC58 genome using MAQ and discarded all reads that did not align uniquely to the 
genome. The quality parameter (2q) used in MAQ pileup was 30. MAQ pileup 
prints an array of delimited information formatted as one line per genomic base. 
Each base is assigned a value for the number of piled sequences and the mapped 
strand for each read, represented by a ‗‗.‘‘ (forward) and ‗‗,‘‘ (reverse). For 
example, Forward strand: all_bases, 7887, G, 45, @.............................................; 
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Reverse strand: all_bases, 914, G, 6, @,,,,,,,; Overlapping Strands: all_bases, 7690, 
G, 38, @,,,,,.,.,,..,,,,,,.................... These data were then mapped strand specifically 
using the perl script maqpileup2depth.pl returning a plot file with two columns 
which can be read into Artemis as a graph by using commands ‗‗Graph, Add User 
Plot‘‘.  
 
1.47 DNase I footprinting 
For footprinting analysis, the promoter region of the aniS gene was amplified with 
the primers 1205-F and 1205-R and cloned into pGEM-T, generating pGem-sR3 
plasmid. The pGem-sR3 plasmid was 5‘end labeled with [γ-32P]ATP at its NcoI 
site and separated from the vector by polyacrylamide gel electrophoresis after 
digestion with SpeI, producing a probe of the aniS promoter region labeled at one 
extremity only, as previously described (Oriente et al., 2010). A recombinant 
constitutively active mutant form of meningococcal FNR (FNRD148A, here stated 
FNRC) was used in binding studies which has been previously described (Oriente et 
al., 2010). DNAse I footprinting experiments with FNRC and the radioactively 
labelled aniS promoter probe were carried out as previously described (Oriente et 
al., 2010). 
 
1.48 Generation of in vitro transcripts 
DNA templates for in vitro transcript generation carrying a T7 polymerase 
promoter were amplified by PCR using genomic MC58 DNA and the primer pairs 
are listed in Table 5. To generate an AniS transcript of 106 nucleotides (nt), a 134-
bp PCR product was generated with the forward primer T7-sR3-F, which contains 
the T7 polymerase promoter (28 bp), and the reverse primer T7-sR3-R, overlapping 
and including the predicted rho-independent terminator sequence of the aniS gene. 
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To test the activity of the rho-independent terminator another PCR product was 
generated for in vitro transcription using the same primer T7-sR3-F and the reverse 
1205-R, which overlaps the putative stop codon of the annotated NMB1205 ORF, 
generating a 183bp that should give rise to a transcript of 155nt. A template for 
generation of a site-directed mutant of AniS (AniS_mut) was generated by 
amplification of 2 overlapping PCR fragments, with primers pairs T7-sR3-F/ss-R 
and ss-F/ T7-sR3-R, which were then using in a self-priming PCR reaction and the 
product was amplified with the T7-sR3-F/T7-sR3-R primer pair. To generate an in 
vitro NMB1468 transcript corresponding to the first 217 nt of the predicted mRNA, 
including 104 nt of 5‘UTR, (starting from the +1 of the predicted promoter) and 
113 nt of the ORF, a template of 244 nt was generated by PCR amplification from 
MC58 genome, using T7-1468-F and T7-1468-R primers. A template for 
generation of a site-directed mutant of NMB1468 (1468_mut) was generated by 
amplification of 2 overlapping PCR fragments, with primers pairs T7-1468-
F/1468ss-R and 1468ss-F/ T7-1468-R, which were then using in a self-priming 
PCR reaction and the product was amplified with the T7-sR3-F/T7-sR3-R primer 
pair. To generate a NrrF transcript of 156 nt, a 184 bp PCR product was generated 
with a forward primer T7-sR-F which contains the T7 polymerase promoter (28 bp) 
and a reverse primer T7-sR-R overlapping and including the predicted rho-
independent terminator sequence of the nrrF gene. For mutagenesis of this template 
the PCR product was cloned in pGemT-easy (Promega) and a deletion spanning 
from +31 to +58, inclusive, of the nrrf gene was generated using QuikChange site-
directed mutagenesis Kit (Stratagene) and del1-f/del1-r the primer pair. The 
template for the mutant tran script was amplified from the resultant plasmid using 
the T7-sR-F/ T7-sR-R primers giving rise to a template of 156 bp for generation of 
the NrrfD31-58 transcript of 128 nt in length. For the 5‘UTR region of the sdhC 
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gene the T7-sC-F/T7sC-R primers were used to amplify a 213 bp PCR fragment 
including the T7 promoter fused from the +1 of transcription to +185 within the 
sdhC gene. To generate a transcript spanning the region of possible 
complementarity overlapping the sdhDA sequence the T7-sA-F/T7-sA-R primers 
were used to amplify a 211bp fragment including the T7 promoter fused to a region 
spanning –96 to +87 with respect to the ATG start site of the sdhA gene. In vitro 
transcription was performed using the MEGAscript High Yield Transcription Kit 
(Ambion) followed by a clean-up step with the MEGAclear kit (Ambion). The 
length and integrity of the in vitro transcripts were analyzed on denaturing 6% 1 
polyacrylamide urea gels. 
 
1.49 Electrophoretic mobility shift assays of in vitro transcription 
products 
To radioactively label AniS, Anis_mut, NrrF and NrrfD31-58 for in vitro binding 
assays with the Hfq protein and/or the possible targets, 20 pmoles of in vitro 
transcription products were dephosphorylated with Calf intestinal phosphatase 
(New England Bioloabs) at 37°C, purified using MegaClear Kit (Ambion) and 5‘ 
end-labeled with 30 μCi of (γ-326 P)-ATP (6000 Ci/mmol; NEN) using 10U of T4 
polynucleotide kinase (New England Biolabs). The unincorporated radioactive 
nucleotides were removed using the TE-30 chromaspin columns (Clontech) and the 
band of the labeled in vitro transcript of appropriate size was extracted after 
electrophoresis on a denaturing 6% polyacrylamide urea gel and eluted overnight at 
4°C in RNA Elution buffer (0.1 M Na Acetate, 0.1% SDS, and 10 mM EDTA). 
After phenol:chloroform extraction the labeled RNA was precipitated by addition 
of 2 volumes of ethanol, and resuspended in water. Binding assays were performed 
with 0.5 pmoles of radioactively labeled probe in 10 μl reactions in 1x RNA 
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binding buffer (10 mM Tris-HCl pH 7, 100 mM KCl, 10 mM MgCl2) with 10 % 
glycerol final concentration. For use in gel shift assays, the Hfq protein was 
dialyzed against 1x RNA binding buffer (10 mM Tris [pH 7], 100 mM KCl, 10 mM 
MgCl2) containing 10% glycerol and then 1x RNA binding buffer with 50% 
glycerol and the concentration was calculated for the hexameric form and stored at 
–20°C. RNA-protein complexes or RNA-RNA duplexes were formed at 37°C for 
10 min in the presence or absence of 10 μg of E. coli tRNA (Boehringer 
Mannheim) as non specific competitor and run on 6% native polyacrilamide gels 
buffered with 0.5 x TBE at 250 Volts for 40 minutes. Gels were dried and exposed 
to autoradiographic films at –80°C and radioactivity was quantified using a 
phosphorimager. 
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TABLES 
 
Table 5: Oligonucleotides used in this study 
Name Sequence Site 
HFQ-1 AttcagaattcGGTTTCCGTGCGGGTGGTAAGGC EcoRI 
HFQ-2 GCTAAAGGACAAATGTTGCAggatccGCACGAAGCATGACGTGTC BamHI 
HFQ-3 GACACGTGATGCTTCGTGCggatccTGCAACATTTGTCCTTTAGC BamHI 
HFQ-4 attcagaagcttACGCGAAGCAGGCAGGTCTATGG HinDIII 
Hfq-F attcagcatATGACAGCTAAAGGACAAATGTTGCAAG NdeI 
Hfq-R attcagctcgagTTATTCGGCAGGCTGCTGGACGGTTTCC XhoI 
Hfq-R-Nsi attcagatgcatTTATTCGGCAGGCTGCTGGACGGTTTCC NsiI 
Hfq-S1 CTCAGGAGAACAACGTATTGATCG  
Hfq-S2 GTTACCATCGTATTGCTGAAtTCGCCCACATC EcoRI 
0747-F  GAAAGTGTGGGCATTCGAC  
0747-R  TTGCTGTAACCTGCTTCCTG  
16S_F  ACGGAGGGTGCGAGCGTTAATC  
16S_R  CTGCCTTCGCCTTCGGTATTCCT  
1205-F attcagaattccacaaaccactgccaaatacagcagt     EcoRI 
1205-R ggttaaagttaagcatttgctgttacgg  
1205-3 ggcagccacacccaaacac  
T7-sR3-F gttttttttaatacgactcactataggATGAAATTCAGGGTGCTTGTTTG  
T7-sR3-R AAAAAAAAGGGGTGGCGGCAG  
Fnr for1 attagcatATGGCTTCGCATAATACTACAC NdeI 
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Fnr rev1 attagggatccTCAAATGGCGTGCGAGC BamHI 
D154A-F GTGAAATCGTGCGCGCCCAAGGTGTTATGCTG  
D154A-R CAGCATAACACCTTGGGCGCGCACGATTTCAC  
sR3-1 attcgatcgatGCTTTGAAGAACTGGGCGAAC SpeI 
sR3-2 TTACTTCACATggatccCAATTTAGATTTTATTCGCAAACCG BamHI 
sR3-3 ATCTAAATTGggatccATGTGAAGTAAAATCCGTAACAGC BamHI 
sR3-4 attcggaattcAGGTTTCCAGTGCTGAAGACAG EcoRI 
Hfq-1 attcagaattcGGTTTCCGTGCGGGTGGTAAGGC EcoRI 
Hfq-4 attcagaagcttACGCGAAGCAGGCAGGTCTATGG HinDIII 
1468-F GTTAAGGAAGCGGTTCAAGC  
1468-R GTTACAGCTTCCTCGGCACT  
0920-F AAGTTCAGCTTGGGTCGTCT  
0920-R TAGTCGCGCAAGACATTACC  
0431-F AGCGAATCACACATCAAAGC  
0431-R TCCGGTAATGCTGGAGTACA  
0577-F TTTACAAAGGCGATGAGCAG  
0577-R TCAATCGGTTTGCTCGAATA  
1584-F CCTCCAAAGACCTCAACCTC  
1584-R CTGCCAGTTTCAGGTAAACG  
1623-F ATGACCATGGAAGACGGTGT  
1623-R CACTTCAACCGTATCGCCTT  
1964-F ACCGACTATGTACGCCCGAA  
1964-R TTCGGTGATGTCCAGATTGT  
16s-F ACGGAGGGTGCGAGCGTTAATC  
16s-R CTGCCTTCGCCTTCGGTATTCCT  
0214-F TCCGCAGGCTATTACAGCTA  
0214-R GACATCGTCGCTTTCTTCAA  
1994-F GCTGGCACAGCTAATACTGC  
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1994-R TCAGCTTTGTTCGTAGCGAT  
0435-F TCGGTATTTCCGAACTTTCC  
0435-R CCATCGAAGCGATGTATTTG  
1572-F CTGCCTGATTTGAAAGTGGA  
1572-R ATCGGCTCTTTGTTGAGCTT  
adk-PE1 CGCGCCTAAAAGTAATGC  
P375-R GGAGGAGCAGGGTTTTCATAGCGGGG  
P375-F CCGCAATGGGTGGAAGCCGCCGC  
1468-pr-F attcagacgtcTTCGGACATCCCGGAATATATTTGGG AatII 
1468-gfp-R attcagctagcCATCATTGCGGCAATCAATAATTTTTTCAT NheI 
AniS-pr attcaggatccCCACTGCCAAATACAGCAGTCC BamHI 
AniS-R attcatctagaGCATTTGCTGTTACGGATTTTACTTCAC XbaI 
ss-R GAGAGGGAAACAGATAAAATCAAGACAAGCGAGGAAACAG  
ss-F ATTTTATCTGTTTCCCTCTCATGTGTGTGTGTTTGGG  
T7-1468-F GTTTTTTTTAATACGACTCACTATAGGTAACTAAACGGGAAACCGTTTTC  
1468ss-F AGGATAACACATGAAAAAATTATTAGCGACCGCAATGATGGCGGC  
1468ss-R ATTTTTTCATGTGTTATCCTCTCCTAGTTGTTGATTAAG  
T7-1468-R ATCGGACTCAACGGCTTGAACCGC  
Sod-pe3  ATGCGTCCAGTTCATAAGGC  
T7-sR-F  GTTTTTTTTAATACGACTCACTATAGGCTCGGAAGCCGTCCGTTCCGAACC  
T7-sR-R  AAACGCCAAACCCACCGCGAAGGTGG  
T7-sC-F GTTTTTTTTAATACGACTCACTATAGGTGTAACCCAGTGTAGCAATGGG  
T7-sC-R2 CAGGAAAGGCAGCATAATAAACAGC  
T7-sA-F GTTTTTTTTAATACGACTCACTATAGGCAAACCCTTCGGCGTGCGTTTG  
T7-sA-R GGATTTGGATAATTGGAGGGCTGC  
del1-f cgttccgaaccattaaaacttggagtcggc  
del1-r cgttccgaaccattaaaacttggagtcggc  
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Capital letters indicate N. meningitidis derived sequences, italicised capital letters indicate E. coli derived sequences, small letters indicate 
sequences added for cloning purposes, and underlined letters indicate recognition sites. 
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Table 6: Deregulated genes in the Hfq null mutant during in vitro logaritmic phase. Only genes major than 2 fold regulated in the Hfq mutant and 
with a p-value ≤0.05 are represented and considered regulated. Fold change values represent a mean of 3 independent experiments each performed 
with a different pool of RNA The NMB number as well as the orientation in the genome and the function based on the classification of TIGRfams 
(Haft et al, 2001) are indicated for each gene 
NMB_ID ORIENTATION GENE NAME 
GENE 
SYMBOL 
MAIN ROLE 
FOLD 
CHANGE 
P VALUE 
NMB0431 + methylcitrate synthase/citrate synthase 2 prpC Energy metabolism 56.72 8.62E-11 
NMB0430 + putative carboxyphosphonoenolpyruvate phosphonomutase  Energy metabolism 28.18 1.31E-10 
NMB0435 + acetate kinase ackA2 Energy metabolism 18.11 2.37E-07 
NMB0429 + hypothetical protein  Hypothetical proteins 17.20 4.26E-13 
NMB0865 - hypothetical protein  Cell envelope 12.76 6.42E-11 
NMB0866 - hypothetical proteine  Hypothetical proteins 8.88 1.99E-06 
NMB0589 - 50s ribosomal protein L19 rplS Protein synthesis 7.27 1.60E-09 
NMB1599 + hypothetical protein  Hypothetical proteins 6.76 1.86E-07 
NMB1584 + 3-hydroxyacid dehydrogenase  
Central intermediary 
metabolism 
6.67 4.00E-09 
NMB1598 + hypothetical protein  Cell envelope 5.61 0.00186389 
NMB1055 - serine hydroxymethyltransferase glyA Biosynthesis of cofactors 5.43 2.88E-07 
NMB0649 + hypothetical protein,  Hypothetical proteins 5.26 3.86E-10 
NMB0325 - 50S ribosomal protein L21 rplU Protein synthesis 5.20 2.11E-08 
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NMB0920 - isocitrate dehydrogenase, NADP-dependent, monomeric type icd Energy metabolism 4.95 4.32E-05 
NMB0650 + hypothetical protein  Hypothetical proteins 4.80 4.63E-08 
NMB0651 + hypothetical protein  Hypothetical proteins 4.75 4.01E-10 
NMB0754 + hypothetical protein  Hypothetical proteins 4.68 1.80E-06 
NMB0317 - conserved hypothetical protein  Hypothetical proteins 4.53 5.72E-05 
NMB1572 + aconitate hydratase 2 acnB Energy metabolism 4.52 4.47E-09 
NMB0316 - conserved hypothetical protein  Hypothetical proteins 4.48 1.50E-06 
NMB0954 + citrate synthase gltA Energy metabolism 4.44 1.25E-10 
NMB1011 + hypothetical protein  Hypothetical proteins 4.42 9.42E-10 
NMB0755 + hypothetical protein  Cell envelope 4.05 0.0069228 
NMB0177 - putative sodium/alanine symporter  
Transport and binding 
proteins 
4.03 3.69E-08 
NMB2136 + peptide transporter  
Transport and binding 
proteins 
3.99 4.95E-10 
NMB0432 + conserved hypothetical protein  Hypothetical proteins 3.89 1.24E-09 
NMB1010 + hypothetical protein  Hypothetical proteins 3.80 3.42E-07 
NMB0864 - hypothetical protein  Cell envelope 3.79 0.0043023 
NMB0324 - 50S ribosomal protein L27 rpmA Protein synthesis 3.74 8.02E-05 
NMB0862 - hypothetical protein  Hypothetical proteins 3.72 2.92E-09 
NMB1600 + hypothetical protein  Hypothetical proteins 3.57 0.000116381 
NMB1406 + hypothetical protein  Hypothetical proteins 3.56 8.31E-05 
NMB0952 + conserved hypothetical protein  Hypothetical proteins 3.53 6.64E-09 
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NMB0953 + hypothetical protein  Cell envelope 3.45 2.10E-05 
NMB0863 - hypothetical protein  Cell envelope 3.41 6.07E-05 
NMB1796 - conserved hypothetical protein  Energy metabolism 3.39 3.73E-05 
NMB2116 + hypothetical protein  Hypothetical proteins 3.39 0.0114239 
NMB0860 - hypothetical protein  Hypothetical proteins 3.31 1.69E-05 
NMB0176 - D-amino acid dehydrogenase, small subunit dadA Energy metabolism 3.27 9.11E-08 
NMB0899 + hypothetical protein  Hypothetical proteins 3.26 1.03E-06 
NMB0660 + hypothetical protein  Hypothetical proteins 3.18 0.049458999 
NMB0229 - conserved hypothetical protein, authentic|frameshift  Hypothetical proteins 3.17 0.00075912 
NMB1009 + conserved hypothetical protein  Hypothetical proteins 3.10 2.07E-05 
NMB1088 - conserved hypothetical protein  Hypothetical proteins 3.05 1.40E-08 
NMB1848 - hypothetical protein  Hypothetical proteins 2.93 0.027465001 
NMB2115 + hypothetical protein  Hypothetical proteins 2.91 0.0044179 
NMB1764 - hypothetical protein  Hypothetical proteins 2.89 4.21E-05 
NMB0858 - hypothetical protein  Hypothetical proteins 2.88 1.85E-05 
NMB1306 + conserved hypothetical protein  Hypothetical proteins 2.83 5.61E-05 
NMB0369 - hypothetical protein  Hypothetical proteins 2.79 0.00145773 
NMB0861 - hypothetical protein  Hypothetical proteins 2.78 0.000122647 
NMB0857 - hypothetical protein  Hypothetical proteins 2.78 2.19E-05 
NMB0433 + aconitate hydratase 1 acnA Energy metabolism 2.77 0.0154206 
NMB0228 - conserved hypothetical protein  Unknown function 2.73 3.77E-08 
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NMB0659 + hypothetical protein  Hypothetical proteins 2.70 0.027744999 
NMB1794 - citrate transporter  
Transport and binding 
proteins 
2.68 0.0042221 
NMB0859 - hypothetical protein  Hypothetical proteins 2.67 0.00033661 
NMB0235 - hypothetical protein  Hypothetical proteins 2.66 0.035964999 
NMB1388 - glucose-6-phosphate isomerase pgi2 Energy metabolism 2.65 7.63E-05 
NMB0574 + glycine cleavage system T protein gcvT Energy metabolism 2.63 4.37E-05 
NMB1946 - outer membrane lipoprotein  Cell envelope 2.60 1.31E-06 
NMB1225 - hypothetical protein  Hypothetical proteins 2.57 0.0059564 
NMB0094 + hypothetical protein,  putative inner membrane protein  Hypothetical proteins 2.56 1.51E-07 
NMB1778 - hypothetical protein  Hypothetical proteins 2.55 5.43E-09 
NMB1777 - hypothetical protein  Hypothetical proteins 2.50 2.05E-06 
NMB0521 + hypothetical protein  Hypothetical proteins 2.49 0.00047833 
NMB2113 + hypothetical protein  Hypothetical proteins 2.48 0.00020436 
NMB0018 - pilin PilE pilE Cell envelope 2.47 7.66E-07 
NMB0609 + 30s ribosomal protein S15 rpsO Protein synthesis 2.46 2.98E-06 
NMB1008 + hypothetical protein  Hypothetical proteins 2.46 8.18E-05 
NMB1107 - hypothetical protein  Hypothetical proteins 2.44 2.13E-05 
NMB0791 - peptidyl-prolyl cis-trans isomerase  Protein fate 2.43 0.000118135 
NMB2111 + MafB-related  Hypothetical proteins 2.41 0.0116247 
NMB1292 - hypothetical protein  Hypothetical proteins 2.39 0.0028034 
NMB0226 - conserved hypothetical protein  Hypothetical proteins 2.39 0.00118358 
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NMB0227 - conserved hypothetical protein,  inner membrane transport   Cell envelope 2.37 0.0068586 
NMB1403 + FrpA/C-related protein  Unknown function 2.36 0.0198009 
NMB1398 + Cu-Zn-superoxide dismutase sodC Cellular processes 2.34 7.05E-07 
NMB1370 - hypothetical protein  Hypothetical proteins 2.34 0.020524001 
NMB2124 + hypothetical protein  Hypothetical proteins 2.34 0.0039806 
NMB1590 - conserved hypothetical protein  Hypothetical proteins 2.33 0.00022209 
NMB1763 - putative toxin-activating protein  Cellular processes 2.31 4.09E-05 
NMB1552 + pilin gene inverting protein  pivNM-1A Cellular processes 2.30 0.000102026 
NMB1458 + fumarate hydratase, class II fumC Energy metabolism 2.29 1.63E-12 
NMB1625 - pilin gene inverting protein   Cellular processes 2.27 0.000140211 
NMB1994 + putative adhesin/invasin nadA Cell envelope 2.22 0 
NMB2013 - hypothetical protein  Hypothetical proteins 2.21 5.19E-07 
NMB0520 + hypothetical protein  Cell envelope 2.20 0.0145028 
NMB0370 - hypothetical protein  
Transport and binding 
proteins 
2.17 1.66E-05 
NMB0083 + capsule polysaccharide modification protein lipB Cell envelope 2.17 1.74E-05 
NMB1865 + hypothetical protein  Hypothetical proteins 2.15 0.044399001 
NMB2114 + MafB-related  Unknown function 2.15 0.0073237 
NMB1634 - conserved hypothetical protein  Hypothetical proteins 2.15 0.0025398 
NMB1525 - VirG-related protein, authentic frameshift  Unknown function 2.15 0.0046596 
NMB1985 - adhesion and penetration protein hap Cellular processes 2.13 8.38E-05 
NMB1404 + hypothetical protein  Cell envelope 2.13 0.00114269 
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NMB1378 + conserved hypothetical protein iscR Regulatory functions 2.11 0.0033604 
NMB0491 - hypothetical protein  Hypothetical proteins 2.11 0.027423 
NMB0367 - hypothetical protein  Hypothetical proteins 2.11 0.00061511 
NMB0093 + hypothetical protein  Hypothetical proteins 2.11 0.0020963 
NMB1289 - putative type II restriction enzyme  DNA metabolism 2.10 0.00035957 
NMB0092 + hypothetical protein  Cell envelope 2.10 0.00103513 
NMB1409 + FrpA/C-related protein  Unknown function 2.09 0.00052141 
NMB0603 - phosphoribosyl-ATP pyrophosphatase hisE Amino acid biosynthesis 2.09 0.00033955 
NMB1753 + VapD-related protein  Unknown function 2.06 0.00044239 
NMB0095 + hypothetical protein,  Hypothetical proteins 2.05 1.48E-07 
NMB0656 + hypothetical protein  Hypothetical proteins 2.04 2.06E-06 
NMB1397 + hypothetical protein  Hypothetical proteins 2.03 0.00053515 
NMB0722 + 50S ribosomal protein L35 rpmI Protein synthesis 2.03 7.97E-05 
NMB0946 + peroxiredoxin 2 family protein/glutaredoxin  cell envelope 2.02 3.94E-06 
NMB0856 - hypothetical protein  Hypothetical proteins 2.01 0.0147642 
NMB0091 + hypothetical protein  Hypothetical proteins 2.00 0.0095215 
NMB0608 + protein-export membrane protein SecF secF Protein fate -2.01 0.00038371 
NMB2081 - hypothetical protein  Cell envelope -2.02 3.18E-06 
NMB2071 + thiG protein thiG Biosynthesis of cofactors -2.02 0.000161736 
NMB1938 - ATP synthase F0, B subunit atpF Energy metabolism -2.02 0.0025764 
NMB0258 + NADH dehydrogenase I, M subunit  Energy metabolism -2.05 0.00140419 
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NMB0568 - Na(+)-translocating NADH-quinone reductase, subunit B nqrB Energy metabolism -2.06 0.00139949 
NMB1624 - hypothetical protein  Hypothetical proteins -2.07 0.000103593 
NMB1344 + 
pyruvate dehydrogenase, E3 component, lipoamide 
dehydrogenase 
lpdA Energy metabolism -2.11 0.00075886 
NMB1617 - putative tellurite resistance protein  Cellular processes -2.13 6.92E-07 
NMB1494 + conserved hypothetical protein  Hypothetical proteins -2.17 0.003384 
NMB1975 + sodium- and chloride-dependent transporter  
Transport and binding 
proteins 
-2.17 0.0025352 
NMB0178 - 
acyl-(acyl-carrier-protein)--UDP-N-acetylglucosamine O-
acyltransferase 
lpxA Cell envelope -2.19 3.51E-05 
NMB0881 - sulfate ABC transporter, permease protein cysU 
Transport and binding 
proteins 
-2.21 0.00131952 
NMB1476 - glutamate dehydrogenase, NAD-specific gluD Amino acid biosynthesis -2.22 3.82E-05 
NMB1934 - ATP synthase F1, beta subunit atpD Energy metabolism -2.24 4.25E-06 
NMB0535 + glucose/galactose transporter gluP 
Transport and binding 
proteins 
-2.24 4.15E-05 
NMB1707 + sodium- and chloride-dependent transporter  
Transport and binding 
proteins 
-2.24 0.000140719 
NMB1722 - cytochrome C555  Disrupted reading frame -2.33 0.0039606 
NMB0905 - hypothetical protein  Hypothetical proteins -2.34 2.03E-05 
NMB0906 - hypothetical protein  Hypothetical proteins -2.40 1.69E-05 
NMB1935 - ATP synthase F1, gamma subunit atpG Energy metabolism -2.41 1.58E-06 
NMB1723 - cytochrome c oxidase, subunit III fixP Energy metabolism -2.42 2.63E-06 
NMB1933 - ATP synthase F1, epsilon subunit atpC Energy metabolism -2.43 0.029418999 
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NMB1493 + carbon starvation protein A cstA Energy metabolism -2.51 6.50E-05 
NMB0904 - hypothetical protein  Cell envelope -2.55 0.020461001 
NMB0607 + protein-export membrane protein SecD secD Protein fate -2.60 0.000143422 
NMB1724 - cytochrome c oxidase, subunit II fixO Energy metabolism -2.61 3.74E-05 
NMB0907 - hypothetical protein  Hypothetical proteins -2.61 0.00022366 
NMB0902 - hypothetical protein  Hypothetical proteins -2.61 2.30E-05 
NMB1725 - cytochrome c oxidase, subunit I fixN Energy metabolism -2.74 4.13E-05 
NMB1365 - conserved hypothetical protein  Hypothetical proteins -2.83 0.00057637 
NMB0903 - hypothetical protein  Hypothetical proteins -2.97 2.14E-05 
NMB0543 - putative L-lactate permease  
Transport and binding 
proteins 
-3.45 1.55E-05 
NMB1623 - major anaerobically induced outer membrane protein pan1/aniA 
central intermediary 
metabolism 
-3.78 0.00046053 
NMB1205 - hypothetical protein aniS Hypothetical proteins -4.31 0.0022756 
NMB0119 - hypothetical protein  Hypothetical proteins -5.45 5.02E-08 
NMB0747 - conserved hypothetical protein  Hypothetical proteins -5.98 0.006558 
NMB0577 + NosR-related protein nosR Regulatory functions -6.00 0.000117817 
NMB0120 - hypothetical protein,  putative inner membrane protein   Hypothetical proteins -7.70 0.003118 
NMB0748 - host factor-I, hfq  hfq Regulatory functions -15.98 2.51E-06 
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